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There are concerns about the usefulness of cotinine and trans-3’-hydroxycotinine 
(3HC), as biomarkers of risk in populations with light tobacco smoke exposure. Using 
CHILD cohort study data, multiple linear and logistic regression was used to determine 
how well questionnaire responses explained urinary concentrations of cotinine and 3HC 
in infants, whether these concentrations predicted childhood asthmatic and 
allergic disease risk, and whether breastmilk facilitated nicotine exposure. Predictive 
models explained 31% and 41% of the variation in cotinine and 3HC, respectively. Only 
23% of the infants had urinary concentrations consistent with second-hand smoke (SHS) 
exposure. The majority (92%) of household smoking occurred outdoors. While smokers 
breastfed less often, breastmilk did facilitate nicotine intake. The implications of dietary 
nicotine sources through breastmilk were inconclusive. Subclinical impacts and the 
pervasiveness of thirdhand smoke pose a challenge for public health and we should re-
evaluate our use and interpretation of nicotine biomarkers in low-smoke exposure 
settings. 
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Tobacco smoke exposure has been studied at length for its negative health effects, 
particularly in children. Passive smoking exposure has been found to induce childhood 
asthma by affecting the balance of T-regulatory and T-helper cells (Jing, Wang, & Liu, 
2019). Exposure to tobacco smoke during the prenatal period and infancy has long been 
of interest when predicting and preventing childhood asthma and wheeze (Silvestri, 
Franchi, Pistorio, Petecchia, & Rusconi, 2015). The recent ‘epidemic’ of childhood 
asthma in North America and other developed countries has been largely attributed to a 
change in our environmental exposures, with a particular interest in gene-environment 
interactions (Sears, 2014). Having tools and measures that properly assess and manage 
these exposures, such as biomarkers, validated questionnaires, and ambient exposures 
measures, has been a challenging and important task posed to scientists, clinicians, and 
decision-makers. Cotinine is perceived as the single best biomarker of tobacco smoke 
exposure (Centers for Disease Control and Prevention, 2016), often used by clinicians 
and researchers to make important decisions and interpretations about the health and 
risky behaviours of an individual or population. The fluidity of physical and social 
contexts is a challenge that pervades even the most renowned and objective measures 
of exposure. Heavily relied-upon measures must be validated and re-validated over time 
and across different populations in order to be helpful for clinical and policy purposes.  
Biomarkers as a Tool for Exposure and Risk Assessment 
When a cigarette is smoked, over 5000 components are released, many of which 
carcinogenic and toxic. However, only a fraction of these can be measured and 
interpreted for their risk based on the existing literature (Talhout et al., 2011). Carbon 
monoxide, ammonia, benzene, arsenic, cyanide, heavy metals, and a number of 
nitrogen oxides and free radical oxidants are some of these compounds (Talhout et al., 
2011). While cigarette smoke is a carcinogen, nicotine itself is not. Instead, nicotine has 
been described as immunosuppressive and can dampen inflammatory responses 
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through both humoral and cell-mediated mechanisms (Piao et al., 2009). Nicotine is an 
important component of cigarettes because it is highly addictive and can be objectively 
measured using biomarkers (Hukkanen, 2005). While it is understood that tobacco 
smoke carries many health risks, nicotine as the culprit for risk associated with exposure 
to tobacco smoke is controversial and incompletely characterized (Piao et al., 2009). 
When nicotine enters the body it is eventually metabolized, primarily by liver enzyme 
CYP2A6, into cotinine and trans-3’-hydroxycotinine which can then be detected in 
samples of urine, serum, hair, and saliva (Benowitz, Hukkanen, Jacob, & III, 2009) 
(Fig.1.1). More than 70% of nicotine is metabolized by the liver enzyme CYP2A6 into 
cotinine, with most metabolism of cotinine results in trans-3’-hydroxycotinine (Benowitz 
et al., 2009; Dempsey et al., 2013). The lungs, spleen, kidneys and liver have the 
highest affinity for nicotine that travels through the bloodstream, and it is known to 
concentrate in amniotic fluid since it easily crosses the placental barrier, fetal serum, and 
breast milk (Benowitz et al., 2009).  
The majority of smoking prevalence is currently held by high-income countries 
but smoking rates are dropping and tobacco companies are now targeting low and 
middle-income countries that have less tobacco control measures in place and who are 
experiencing economic upturns, meaning that the weight of tobacco-related morbidity is 
shifting from high to lower income countries (Lange, Probst, Rehm, & Popova, 2018). As 
a result, research in the past decade relating to tobacco smoke exposure has shifted 
from the health effects of first-hand smoking to that of second-hand smoking (SHS) risks 
in developed countries (Bird & Staines-Orozco, 2016; Zhou et al., 2014). In addition, the 
sensitivity of biomarker testing has increased, resulting in detection of lower 
concentrations and the ability to measure lower concentrations of nicotine metabolites. In 
populations characterized as having relatively low tobacco smoke exposure, the ability of 
urinary cotinine to predict clinical outcomes related to respiratory and allergic disease, 
known outcomes of tobacco smoke exposure, has been brought into question (Benowitz, 
Jain, Dempsey, Nardone, Helen, et al., 2017; Bramer & Kallungal, 2003). Some experts 
are now suggesting further investigation of whether dietary sources of nicotine, such as 
peppers and eggplant, can influence the levels of nicotine detected in children and 
infants, particularly in populations with a low prevalence of smoking (Hovell, Zakarian, 
Wahlgren, Matt, & Emmons, 2000). 
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Recent work has found that cotinine alone is a poor measure of one’s reported 
tobacco smoke exposure, particularly at lower levels (Benowitz, Jain, Dempsey, 
Nardone, St. Helen, et al., 2017; McLean, 2013; Torres et al., 2018). Despite this, some 
studies still use urinary cotinine biomarkers as the sole measure of tobacco smoke 
exposure. While cotinine and trans-3’-hydroxycotinine concentrations remain an 
objective way of verifying questionnaire reported tobacco smoking exposure, it appears 
to be less helpful or reliable in verifying little to no exposure.  
Building a Multifaceted Approach to Understanding the Context of Tobacco 
Smoke Exposure to Infants.  
Understanding who is exposed to tobacco smoke and how much they are exposed, what 
causes this exposure, when exposure occurs and how it changes over time, where they 
are most exposed, and why some are more exposed to tobacco smoke than others is 
key to deciding how to best measure, predict, and prevent this exposure. This thesis 
takes a multifaceted approach to understanding the current context of tobacco smoke 
exposure to Canadian infants using a combination of questionnaire, biomarker samples, 
and machine learning, and incorporates valuable health outcome and dietary data 
available from the CHILD Cohort Study. 
 
Figure 1.1. Nicotine Metabolism 
Image by Jaclyn Parks. June 2020 
Significance of Thesis Findings 
As more sensitive tests with lower levels of detection have been put into practice, and 
the rates of smoking have dropped in Canada and other developed countries, little has 
been done to identify sources of low, but detectable levels of cotinine and rule out 
dietary nicotine as a potential source. If analysis shows that cotinine levels in the 
majority of our sample are unhelpful in clinical diagnosis, and that vegetable intake is 
significantly associated with cotinine concentrations amongst those with low tobacco 
exposure, the scientific application of cotinine as a biomarker of tobacco smoke will need 
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to change. This project will allow for a better understanding of how our biomarker data 
should be applied within the CHILD Study, and how nicotine metabolites should be 
considered and interpreted as biomarkers by future environmental health researchers.	 
1.2. Research Objectives, Study Population 
The objectives of this thesis are as follows: 
1) What are the levels and key sources of nicotine metabolites in a 
population of urban, Canadian infants? 
2) Does diet contribute to low but detectable levels of cotinine in 
children? and 
3) What are the clinical implications and relevance of these 
concentrations? 
Specific research objectives are as follows: 
• Using basic summary statistics and ANOVA to determine the levels of nicotine 
metabolites in infants and which predictors best explain differences in the 
concentration of these metabolites (Chapter 2). 
• Use a combination of traditional model selection and machine learning to 
derive optimized models for predicting urinary metabolites of nicotine (Chapter 
2). 
• Determine how well a questionnaire-based prediction model can explain 
variation in urinary concentrations of cotinine and trans-3’-hydroxycotinine 
(Chapter 2). 
• Discuss the research implications and the relevance of tobacco smoke 
exposure in this population to public health officials, researchers and clinicians 
(Chapter 2). 
• Assess the relationship between nicotine metabolite concentrations in infants 
and respiratory and allergic health risks in childhood (Chapter 3). 
• Explore whether infant diet and breastfeeding may help to predict variation in 
cotinine and 3HC concentrations amongst our study sample (Chapter 3). 
• Determine if a maternal diet high in vegetables is associated with higher levels 
of cotinine in breastfeeding infants, and how this affects our understanding of 
nicotine metabolites as indicators of asthma risk for children (Chapter 3). 
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The CHILD Cohort Study 
This MSc thesis will use data from the CHILD Cohort Study. The CHILD Cohort Study is 
the largest longitudinal cohort in Canada, with approximately 3,500 participants and their 
families followed from pregnancy until age 8, with intentions to follow subjects into 
adolescence. 3455 eligible children were recruited from largely-urban centers in 4 
provinces across Canada (Vancouver, BC; Edmonton, AB; Winnipeg, Morden, and 
Winkler, MB, and Toronto, ON) to reflect the general Canadian, largely urban, population 
(Takaro et al., 2015). Using a comprehensive suite of exposure assessments, 
questionnaires, clinical measurements, and household and biomarker sampling, the 
CHILD Cohort study works primarily to understand how environmental exposures and 
genetics affect the risk of developing childhood asthma and allergies. Questionnaires 
relating to environmental exposures, psychosocial stresses, nutrition, and general health 
were completed by parents at recruitment in the second or third trimesters, and at ages 
3, 6, 12, 18, 24, 30 and 36 months (Takaro et al., 2015). Periodic clinical assessments, 
skin prick tests, and biological sampling of subjects was also completed. The focus on 
inflammatory exposures in early life, as well as data on clinical and subclinical outcomes 
and dietary information makes the CHILD Cohort study the ideal population to address 
the objectives of this thesis.  
1.3. Thesis Structure 
This thesis consists of 2 papers suitable for peer-reviewed publication in the form of 
stand-alone chapters (Chapter 2, and 3) that each address one of the specific objectives 
outlined earlier, as well as a concluding chapter (Chapter 4).  
Chapter 2 outlines the current state of smoking, exposure levels and sources of 
exposure to infants, and the limitations of strict use of biomarkers or questionnaire to 
understand the context of tobacco smoke exposure in infants. Concentration cut-offs for 
characterizing little to no smoke exposure to those with some second-hand smoke (SHS) 
exposure, and those with regular SHS exposure. Chapter 3 explores the relationship 
between breastfeeding, tobacco smoke exposure, and metabolized nicotine detected in 
infants. Chapter 4 concludes the thesis by highlighting the contribution of each paper 
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As smoking rates have dropped in Canada, the use of traditional tobacco smoke 
biomarkers in infants needs re-evaluation. 
Objective 
The objectives are to examine concentrations of nicotine biomarkers, their relationship 
with questionnaire responses to machine learning and prediction modeling to determine 
the extent and sources of tobacco smoke exposure for infants in urbanized Canadian 
families.  
Methods 
Questionnaire responses and infant urine samples from the CHILD cohort study were 
examined using multivariable linear regression models, chosen through a combination of 
conceptual and data-driven strategies including random forest regression to assess the 
ability of questionnaires to predict variation in biomarkers of tobacco smoke exposure: 
urinary cotinine and trans-3’-hydroxycotinine (3HC). 
Results 
Despite 2% of women in our sample smoking prior to and continuing through their 
pregnancy, we detected cotinine in the urine of 76% of the sample (n=2,017) and 3HC in 
89%. Questionnaire-based models explained 31% and 41% of the adjusted R2 variance 
in cotinine and 3HC levels, respectively. In addition to reported second-hand smoke 
exposure, housing characteristics, breastfeeding and reservoirs of third-hand smoke 
predicted nicotine metabolite concentrations. We identified general cut-points in cotinine 
and 3HC concentrations to characterize SHS exposure (0.25ng/mL and 0.50ng/mL). 
Significance 
Consistent with previous studies, prediction models for tobacco smoke exposure did not 
substantially explain much of the variation of cotinine and 3HC in a population with low 
but ubiquitous exposure. The use of these metabolites alone to measure tobacco smoke 
exposure remains problematic in this population. The ability of machine learning 
approaches to inform predictive modeling, the pervasiveness of thirdhand smoke 
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exposure, and the potential for non-smoke sourced nicotine to impact risk should be 
explored further.  
2.2. Introduction  
Tobacco smoke exposure has been studied at length for its negative health effects and 
is known to be particularly harmful to children (Chilmonczyk et al., 1993). Research in 
the past two decades relating to tobacco smoke exposure has shifted from the health 
effects of first-hand smoking to that of second-hand smoking (SHS) (Bird & Staines-
Orozco, 2016; Lee et al., 2019; Zhou et al., 2014). SHS both in utero and in childhood 
has been repeatedly linked to asthma, as well as sudden infant death syndrome, low 
birth weight, cancer, dental caries, hearing loss and metabolic syndromes along with a 
breadth of poor behavioural and cognitive outcomes (Bruin, Gerstein, & Holloway, 2010; 
Zhou et al., 2014).  
Accurately assessing prenatal and early life tobacco smoke exposure is 
important in understanding and preventing childhood asthma and wheeze (Silvestri, 
Franchi, Pistorio, Petecchia, & Rusconi, 2015). Questionnaires are a flexible and 
relatively inexpensive method of assessing exposure, but biomarkers of tobacco smoke 
exposure are more accurate, objective and can be obtained with little burden to the 
subject, such as in the case of passive urine sample collection. Nicotine is an important 
component of cigarettes for researchers because it can be detected in humans using 
biomarkers (Hukkanen, 2005). While there are many metabolites of nicotine that can be 
analyzed, cotinine is the most widely used biomarker of recent tobacco smoke exposure 
and has an average half-life of 16-19 hours in children ages 2 months to 4 years 
(Benowitz, Hukkanen, Jacob, & III, 2009; D. A. Dempsey et al., 2013). Cotinine, a 
metabolite of nicotine, is still heralded as the best biomarker of tobacco smoke exposure 
(Centers for Disease Control and Prevention, 2016). More than 70% of nicotine is 
metabolized into cotinine, with all metabolism of cotinine resulting in trans 3’-
hydroxycotinine (3HC) (D. A. Dempsey et al., 2013). While cotinine and 3HC 
concentrations remain an unbiased way of verifying recent tobacco smoking exposure, 
they are less reliable in verifying little to no SHS exposure.  
The environmental context in which cotinine has been used by researchers is 
changing. As tests with lower levels-of-detection have been put into practice, and 
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smoking rates have dropped in Canada and other developed countries, there are gaps in 
our knowledge of how these refinements may impact the use  of this biomarker for public 
health, including identifying sources of low concentrations of nicotine. When smoking 
prevalence was higher, the use of cotinine to measure tobacco smoke exposure was 
warranted as it aided in verification of the confirmed exposure levels. However, over the 
past two decades the Canadian rates of smoking have been dropping, particularly during 
pregnancy and when around children. This is a combined result of policy, increased 
awareness, product labelling, clinician counseling and social pressures (Al-Sahab, 
Saqib, Hauser, & Tamim, 2010; Asbridge, 2004; Cawkwell, Lee, Shearston, Sherman, & 
Weitzman, 2016; Centers for Disease Control and Prevention, 2016; Hammond, Fong, & 
Mcdonald, 2003; Millar & Hill, 2004; Noar et al., 2016; Sánchez-Rodríguez et al., 
2015).  During the 1990’s, the rates of smoking during pregnancy were estimated to be 
24% in Canada (Connor & McIntyre, 1999), which dropped to approximately 17% in 
2000 (Millar & Hill, 2004), 11% in 2006 (Al-Sahab et al., 2010), and have continued to 
decline since. 
The purpose of this study is to better understand cotinine and 3HC as biomarkers 
of tobacco smoked exposure in a population with little to no reported tobacco smoke 
exposure. The research questions are “What is the context of tobacco smoke exposure 
in a population of Canadian infants”, “What are the key sources of tobacco smoke 
exposure”, and “What are the research implications and the relevance of the context of 
smoke to policy-makers, researchers and clinicians?”. This project will allow for a better 
understanding of how our biomarker data should be organized within cohorts like the 
CHILD Study, and how low-level nicotine metabolites should be considered and 
interpreted as biomarkers by future environmental health researchers. 
2.3. Materials/Participants and Methods 
The cohort 
This study uses of secondary data from the CHILD Cohort Study, a four centre 
(Vancouver, Edmonton, Winnipeg and Toronto) longitudinal, population-based birth-
cohort study which enrolled 3,455 mother-child pairs between 2008 and 2012 with 
planned five-year follow-up. The main focus of CHILD is to identify environmental and 
genetic determinants of allergic disorders and asthma. The demographic characteristics 
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of the cohort are linked to reduced smoking rates relative to the general Canadian 
population, with a very small proportion of mothers in the study reporting that they 
smoked during pregnancy or during the child’s early life (McLean, 2013). Data was 
collected using a combination of questionnaires, in-home visits, and urine samples.  
The urine samples 
Urine samples were collected by trained research assistants during the 3-month in-home 
visits. The procedure involved placing a plastic Tegaderm™ film over the wetting area of 
the baby’s diaper to prevent urine absorption by the diaper. Cotton pads were placed on 
top of the film and the baby then wore the diaper for the duration of the home visit. At the 
end of the visit, the mother removed the diaper, and the research assistant placed the 
cotton pads into a syringe, aliquoted the sample into six vials, and measured the specific 
gravity of the sample using a calibrated refractometer. The samples were stored at -80 
degrees Celsius (Takaro et al., 2015). In the laboratory, β-glucuronidase was used to de-
conjugate any glucoronidated cotinine and 3HC molecules. After extraction, the samples 
were analyzed by liquid chromatography-atmospheric pressure chemical ionization 
tandem mass spectrometry (LC-APCI-MS). Analyte concentrations were calculated 
using least-squares linear regression of the peak area ratios of native to internal 
standards. The limit of detection for both cotinine and 3HC was 0.030 ng/mL. 
To account for dilution of the urine samples, biomarker concentrations were 
corrected for specific gravity (McLean, 2013; Takaro et al., 2015). Samples with specific 
gravity (SG) measurements outside the normal human range (3 standard deviations 
above the median) were excluded from the analysis. Since the metabolite concentrations 
were approximately log-normally distributed, the concentrations were log-transformed 
(base 2) prior to SG correction. Concentrations below the 0.03 ng/mL level of detection 
were imputed using a truncated method (Lubin et al., 2004) (See Appendix). 
Concentrations were determined for each of the two metabolites separately, as well as 
on the sum of the two concentrations on a molar basis (picomole/mL). 
Predictor variables 
The exposure variables are taken from three sources; a questionnaire completed by the 
mother during pregnancy, a parent-completed household exposures questionnaire at 3 
months, and a research assistant-completed questionnaire on household exposures 
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completed at the 3-month home visit. Potential predictors of exposure were derived from 
questionnaires which captured smoking-related exposure, housing characteristics, and 
demographics that have been linked in the literature to tobacco smoke exposure, be it 
second-hand, or third-hand (Tables 3a-c) (Benowitz, Dains, et al., 2009; Burton, 2011; 
Chen et al., 2016; Dahlström, Ebersjö, & Lundell, 2004; El-Mohandes, Kiely, Blake, 
Gantz, & El-Khorazaty, 2010; Hukkanen, 2005; Ray, Tyndale, & Lerman, 2009). Third-
hand smoke results from second-hand smoke that has been absorbed onto surfaces 
such as carpeting and upholstery, or settled on dust where it can persist a long period of 
time and be released into the air long after a smoking event (Burton, 2011). 
Geometric means and 95% confidence intervals of both cotinine and 3HC 
concentrations were calculated for the levels of each potential predictor variable. For 
normally distributed variables, we used t-tests or one-way analysis of variance (ANOVA) 
tests were used to assess whether the difference in means between levels or groups of 
a variable were statistically significant. When an ANOVA test was significant, Tukey 
Honest Significant Differences (Tukey-HSD) tests were run to assess multiple pairwise 
comparisons between multiple levels of a predictor. ANOVA and t-tests assume 
normality in the distribution of the means being compared. For non-normally distributed 
variable (determined using a Shapiro-Wilk test), a Wilcoxon test was used in place of a t-
test, and a Kruskal-Wallis test in place of an ANOVA analysis. Spearman correlation 
tests were used when comparing the biomarker concentrations to a continuous predictor 
variable. The complete tables of geometric means by predictor and a dictionary of 
predictors considered are available in the appendix. 
Incorporation of Random Forest Regression in Prediction Model Selection 
A random forest regression (RFR) of all potential predictor variables (a priori) against 
each metabolite concentration assigned variable importance scores to each predictor. 
RFR is one example of a machine learning technique used to allow a system to 
automatically learn from the data and produce results with minimal subjective bias, 
offering an objective perspective on the variable selection process. The RFR was set to 
run models on 1000 trees, a relatively large number for RFR, to help ensure that the 
average model fit best reflects the data and avoids overfitting from using too few trees. 
These variable importance scores reflected the overall influence of the predictor in a 
prediction model, by showing how much the mean squared error (MSE) of a model 
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would increase as a result of the predictor being excluded from the model. The MSE is a 
measure of closeness of a fitted line to actual data points. MSE values are bounded 
between zero to infinity. The smaller the MSE, the closer the fit is to the data. Having a 
model with variables of high importance will result in a lower MSE.  
Using variable importance scores derived from RFR, I created multivariable linear 
regression (MLR) models to predict urinary concentrations as the outcome. A MLR 
model was then selected based on questionnaire variables identified as ‘important’, and 
a-priori assessment to best explain the cotinine concentrations of the sample with 
detectable metabolite date. The models were built using manual selection, starting with 
the predictor with the highest variable importance score. The predictor with the next 
highest score was then added to the model. The added predictor was included if it had 
appropriate directionality, increased the model’s coefficient of determination (R2), and 
was reasonably statistically significant (p<0.15). This was repeated for many predictor 
variables (see Appendix) until it was clear that adding more predictors did not further 
improve model performance. The coefficient of determination and measures of model fit 
were then used to determine how well questionnaire-based models explain variation in 
urinary cotinine concentrations in infants. This process was repeated for 3HC, as some 
variables may be more important for one metabolite than another. Plots of predicted 
versus observed biomarker concentrations were created for each final model to assess 
model fit. Coefficients and their 95% confidence intervals were reported for each 
predictor in the final MLR models against the log-transformed cotinine or 3HC 
concentration. These coefficients were then inverse-log-transformed to reflect the 
multiplicative change in urinary concentration (i.e. 1.10 means a 10% increase in 
concentration). The coefficients and back-transformations from unadjusted regression 
against the log-transformed urinary concentrations were also calculated for each 
predictor. 
A 10-fold cross validation (CV) was also applied to the final trans-3’-
hydroxycotinine and cotinine prediction models to evaluate prediction error for both 
models:  
(1) The dataset was randomly divided into 10 sub-groups with 
approximately the same number of observations in each group.  
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(2) The predictive model was parameterized based on data from 9 of the 
10 groups.  
(3) The estimated coefficients were used to predict log transformed 
urinary cotinine (or trans-3’-hydroxycotinine) concentrations for 
observations in the excluded group.  
(4) Steps (1) – (3) were repeated to obtain predictions for all 10 groups 
and, therefore, all observations.  
(5) Log transformed urinary concentration predictions and measurements 
on the untransformed scale were compared and model performance 
was evaluated based on R2. 
Characterizing exposure based on cut-points 
Biomarkers can also be used to predict or verify the exposure level of participants. 
Density plots of the urinary metabolite concentrations by important questionnaire 
questions were used to examine the separation of the participants by questionnaire 
response (Dostál et al., 2008). We then compared density proportions of these 
responses within cut-point bounds to gain consensus about what average concentration 
is found in those who likely have no household exposure, those who have some light 
exposure, and those who have confirmed household second-hand smoke exposure. In 
some cases, these levels were continuous (eg. week of gestation that mother quit 
smoking), while others were factors (eg. Location) or ordinal factors (eg. household 
income). Recommended cut-points for urinary cotinine concentrations were assessed 
(Benowitz et al., 2017).  
Statistical Software and Ethics 
Analysis was completed using R version 3.5.1 (2018-07-02). Ethics approval was 
obtained through Simon Fraser University, deeming this project to be a minimal risk 
study [project number 2018s0608]. Research ethics approval for the overall CHILD study 
was obtained at each recruitment site and through the Hamilton Integrated Ethics Board 





Of 2,017 infants with complete data (Appendix A, Fig.1), 76% had detectable cotinine 
and 89% had detectable hydroxy-cotinine (3HC) levels. Participants from Manitoba 
(Winnipeg, Morden, and Winkler) made up the largest proportion of our sample (31%), 
followed by Vancouver (27%), Edmonton (22%), and Toronto (20%). More than half of 
our participants had a household income over $100,000/year (55%), lived in a single-
family home (56%), and had a mother over age 30 (60%). 34% lived in a rented home, 
and 31% had at least one parent with asthmatic history of disease. Less than 3% 
reported actively smoking during their pregnancy, while 21% reported being recently 
exposed to smoke during pregnancy. 17.7% of mothers were smokers but had quit prior 
to their pregnancy. Of the 6% of our sample who did not quit prior to their pregnancy, 
64% reported quitting during the pregnancy, leaving just 2% who continued to smoke 
throughout their pregnancy. 62% of mothers were exclusively breastfeeding their child, 
26% were partially breastfeeding, and 12% reported not breastfeeding their child at 3-4 
months of age. Only 12% reported that smoking had occurred at the home since the 
child’s birth, with the majority of household smoking occurring outdoors.  
After correcting for urine dilution and imputing those below detection (Appendix 
A) the geometric mean cotinine concentration of our sample was 0.12 ng/mL (95% CI: 
0.11-0.13), and geometric mean 3HC concentration was 0.22 ng/mL (95% CI: 0.21-0.24) 
and a combination of them both had a mean of 2.13 pmole/mL (95% CI; 1.98-2.28). The 
arithmetic mean (and Median) concentrations for cotinine were 1.87 ng/mL (Median 0.08 




Table 2.1. Demographic Characteristics 
Characteristic % (N) Geometric mean 
urinary Cotinine  




(95% CI), ng/mL 
Study Centre 
Vancouver 26.7% (n=539) 0.10 (0.09-0.12) 0.16 (0.14-0.18) 
Edmonton 19.9% (n=402) 0.13 (0.11-0.15) 0.28 (0.23-0.34) 
Winnipeg, Morden, 
Winkler 
30.9% (n=624) 0.14 (0.12-0.16) 0.29 (0.25-0.34) 
Toronto 22.4% (n=452) 0.09 (0.08-0.10) 0.20 (0.17-0.22) 
Difference in means, p-value p<0.001 p<0.001 
Household Income 
$0-49,999/year 10.0% (n=201) 0.26 (0.20-0.34) 0.55 (0.43-0.76) 
$50,000-99,999/year 31.3% (n=631) 0.14 (0.12-0.16) 0.26 (0.22-0.29) 
$100,000-
149,999/year 
26.4% (n=533) 0.09 (0.08-0.11) 0.19 (0.16-0.21) 
$150,000+/year 23.3% (n=469) 0.08 (0.07-0.09) 0.14 (0.12-0.16) 
Prefers to not say 9.1% (n=183) 0.12 (0.10-0.15) 0.28 (0.22-0.36) 
Difference in means, p-value p<0.001 p<0.001 
Maternal Age at Enrolment 
17 to 23 years old 3.8% (n=77) 0.42 (0.28-0.64) 1.01 (0.64-1.60) 
24 to 30 years old 32.2% (n=649) 0.14 (0.12-0.16) 0.29 (0.25-0.33) 
31 to 35 years old 41.9% (n=845) 0.10 (0.09-0.11) 0.19 (0.17-0.21) 
36-46 years old 22.1% (n=446) 0.09 (0.08-0.11) 0.17 (0.15-0.20) 
Difference in means, p-value p<0.001 p<0.001 
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Characteristic % (N) Geometric mean 
urinary Cotinine  




(95% CI), ng/mL 
Child’s Sex 
Male 52.9% (n=1067) 0.11 (0.10-0.13) 0.20 (0.18-0.23) 
Female 47.1% (n=950) 0.12 (0.10-0.13) 0.23 (0.20-0.26) 
Difference in means, p-value p=0.86 p=0.26 
Parental Asthma 
Yes 31.3% (n=660) 0.13 (0.12-0.15) 0.24 (0.21-0.27) 
No 67.3% (n=1357) 0.11 (0.10-0.12) 0.22 (0.20-0.24) 
Difference in means, p-value p=0.03 p=0.11 
Rent vs. Own Home 
Rent 23.2% (n=467) 0.19 (0.16-0.22) 0.36 (0.31-0.43) 
Own 76.8% (n=1550) 0.10 (0.09-0.11) 0.19 (0.18-0.21) 
Difference in means, p-value p<0.001 p<0.001 
Dwelling Type 
Single Family  55.8% (n=1470) 0.10 (0.10-0.11) 0.20 (0.18-0.22) 
Multi-Family or 
Apartment 
25.8% (n=521) 0.15 (0.13-0.18) 0.29 (0.25-0.34) 
Trailer or Other 1.2% (n=26) 0.24 (0.11-0.49) 0.53 (0.23-1.19) 
Difference in means, p-value p<0.001 p<0.001 
Breastfeeding Status 
None 12.0% (n=243) 0.16 (0.13-0.19) 0.29 (0.23-0.36) 
Partial 25.8% (n=520) 0.12 (0.10-0.14) 0.24 (0.20-0.28) 
Exclusive 62.2% (n=1254) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Difference in means, p-value p=0.005 p=0.16 
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Characteristic % (N) Geometric mean 
urinary Cotinine  




(95% CI), ng/mL 
Someone has smoked at the home since birth 
No smoking at the 
home 
87.8% (n=1771) 0.10 (0.09-0.10) 0.17 (0.16-0.19) 
Yes, smoking at the 
home 
12.2% (n=246) 0.50 (0.38-0.65) 1.36 (1.02-1.81) 
Difference in means, p-value p<0.001 p<0.001 
Location of household smoking during child’s early life 
Inside 0.5% (n=10) 2.07 (0.79-5.44) 6.45 (2.50-16.63) 
Near a Window or in 
Garage 
1.6% (n=32) 1.30 (0.63-2.71) 4.18 (1.98-8.85) 
Outside 11.2% (n=225) 0.43 (0.33-0.57) 1.16 (0.86-1.57) 
Difference in means, p-value p<0.001 p<0.001 
Mother reports smoke exposure during pregnancy 
Recent Exposure 21.1% (n=425) 0.29 (0.24-0.35) 0.66 (0.54-0.81) 
No recent exposures 78.9% (n=1592) 0.09 (0.08-0.10) 0.29 (0.24-0.35) 
Difference in means, p-value p<0.001 p<0.001 
Maternal smoking status in pregnancy 
Never Smoked 97.5% (n=1967) 0.10 (0.10-0.11) 0.20 (0.19-0.21) 
Daily or Occasional 
Smoker 
2.6% (n=50) 7.13 (4.18-12.14) 21.96 (12.21-39.48) 
Difference in means, p-value p<0.001 p<0.001 
The proportion and crude number of sample subjects that corresponds to each level of household characteristic 
variables is reported to the nearest whole number. The geometric mean (95% Confidence interval) of the corrected and 
log-transformed Cotinine distribution for each level of each variable is also shown. P-values indicate whether the 




Table 2.2. Summary statistics of each metabolite 
Metabolite 10th % 25th % 50th % Mean 75th % 90th % SD Geometric 
mean (95% CI) 
Cotinine* 0.02 0.04 0.08 1.87 0.23 0.77 13.73 0.12 (0.11-0.13) 
3HC* 0.04 0.07 0.16 6.67 0.45 1.90 67.84 0.22 (0.21-0.24) 
Molar Sum*  0.47 0.73 1.42 45.35 3.95 16.62 385.9 2.13 (1.98-2.28) 
*Corrected for specific gravity and with concentrations imputed below the level of detection. Cotinine and 3HC are 
measured in units of ng/mL, while a combination of both are reported in picomole/mL as they were combined on a 
molar basis. SD = standard deviation; IQR = interquartile range. 
Based on geometric mean concentrations (Appendix A) and density plots 
(Fig.2.1a-c), those who report no known exposure to tobacco smoke have a geometric 
mean urinary cotinine concentration of 0.09-0.12ng/mL, while those who report some 
exposure have more variable range, and those with reported second-hand smoke 
exposure have an average cotinine concentration of at least 0.25 ng/mL depending on 
the characterizing question. Applying cut-points of presumed exposure to our samples, 
based on threshold identified by Benowitz et al for a population of adolescents with low 
smoking exposure (Benowitz et al., 2017), we suspect that 1.6% (n=33) of our sample 
are actively exposed or exposed to recent heavy second-hand smoke (>=30ng/mL), 
21.9% (n=441) were exposed to second-hand smoke (0.25-30ng/mL), and 76.5% 
(n=1,543) were exposed to light, third-hand smoke or none at all (<0.25 ng/mL). The 
same concentration thresholds did not apply well to 3HC concentrations, so thresholds 
of 0.25ng/mL and 30ng/mL were doubled (Figures 2.1a-c).  
The selected MLR models predicted 31% of the log-transformed cotinine 
concentration using 13 predictors and 41% of the variation in the log-transformed 3HC 
concentration using 19 predictors (Figures 2.3a-b and 2.4a-b). 3HC may require more 
predictors because its higher concentrations are more sensitive to a breadth of exposure 
sources. 10-fold cross validation found that the models performed slightly poorer, at 30% 
and 37%, respectively. When the same model that was used to predict cotinine was 
used to predict the 3HC concentration, it explained less of the variation in 3HC than the 
3HC-optimized model (R2 38.46%). Predictors from the cotinine model explained 35.1% 
of the variation in the log-transformed combined molar concentration, while predictors 
from the 3HC model were able to explain 36.5% of the combined concentration. 10-fold 
cross-validation found that the cotinine model explained 30%, and the 3HC model 
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explained 37% of the variation in the measured log-transformed combined molar 
concentration. The most important predictors appear to be whether or not the mother 
smoked and/or quit prior to the pregnancy, the number of cigarettes smoked at the home 
during the pregnancy, and whether someone had smoked at the home since the child’s 
birth, though all predictors added value to the model. Adjusted model coefficients show 
that those who had not quit prior to their pregnancy had an infant with twice the urinary 
cotinine concentration of mothers who never smoked, and mothers actively smoking 
during their pregnancy had an infant with more than 5 times the urinary cotinine 





Figure 2.1a.  Density plots of log-transformed cotinine and 3HC concentrations 
based on maternal smoking status during pregnancy 
Density plots show the distribution of the log-transformed cotinine (top) and trans-3’-
hydroxycotinine (3HC) (bottom) concentrations based on response to “Did the mother quit 
smoking during the pregnancy?”. Vertical lines indicate cut-offs of assumed exposure to tobacco 
smoke. The left group likely experienced very little to no SHS or THS, the middle had some light 
SHS, and those to the far-right had regular exposure to SHS. The dashed lines reflect 0.25 ng/mL 





Figure 2.1b.  Density plots of log-transformed cotinine and 3HC concentrations 
based on the number of daily cigarettes smoked at the home in early 
life 
Density plots show the distribution of the log-transformed cotinine (top) and 3HC (bottom) 
concentrations based on response to “How many cigarettes (on average) are smoked at the 
home daily in the child’s early life?”. Vertical lines indicate cut-offs of assumed exposure to 
tobacco smoke. The left group likely experienced very little to no SHS or THS, the middle had 
some light SHS, and those to the far-right had regular exposure to SHS. The dashed lines reflect 





Figure 2.1c.  Density plots of log-transformed cotinine and 3HC concentrations 
based on whether someone smoked at the home during pregnancy 
Density plots show the distribution of the log-transformed cotinine (top) and trans-3’-
hydroxycotinine (bottom) concentrations based on response to “How many smokers lived at the 
home during pregnancy?”. Density curves were not created for response categories which 2 or 
fewer subjects selected. Vertical lines indicate cut-offs of assumed exposure to tobacco smoke. 
The left group likely experienced very little to no SHS or THS, the middle had some light SHS, 
and those to the far-right had regular exposure to SHS. The dashed lines reflect 0.25 ng/mL and 




Figure 2.3a.  Cotinine Multivariable Linear Regression Model 
Coefficients (point) and their 95% confidence intervals (line) are displayed for each variable in a 
model predicting log-transformed urinary cotinine concentration the prediction mode. Variables 
related to second-hand smoke are shown in red, not smoking-related variables in blue, and 
variables related to household characteristics in grey. Intervals with a point estimate displayed as 
a circle are based on bivariate analysis between each predictor and urinary cotinine, while 
estimates displayed with a triangle reflect estimates from multivariable model. 
 
Mother did not quit smoking prior to pregnancy vs. Never smoked
Mother quit smoking prior to pregnancy vs. Never smoked
Mother smoked daily or occasionally during pregnancy vs. Never smoked
Days exposed to cigarette smoke in past 2 weeks during pregnancy
Week of gestation when mother quit smoking
Week of gestation when mother cut down smoking
Less than 1 cigarette smoked daily at the home during pregnancy
1−5 cigarette smoked daily at the home during pregnancy
6−10 cigarettes smoked daily at the home during pregnancy
11+ cigarettes smoked daily at the home during pregnancy
Household smoking since birth vs. None
1−5 cigarette smoked daily at the home since birth
6−10 cigarettes smoked daily at the home since birth
11+ cigarettes smoked daily at the home since birth
Partially vs. exclusively breastfed
Not breastfed vs. exclusively breastfed
Apartment/Multi−family vs. Single−Family detached home
Trailer/other vs. Single−family detached home
Household income is $50,000−99,999/year vs. <$50,000/year
Household income is $100,000−149,999/year vs. <$50,000/year
Household income is $150,000+/year vs. <$50,000/year
Household income is not disclosed vs. <$50,000/year
Father has some post−secondary education vs. Highschool or less
Father has completed post−secondary education vs. Highschool or less
Father has Masters or PhD education vs. Highschool or less















Predictor Coefficients Modelled against Cotinine
Mother did not quit smoking prior to pregnancy vs. Never smoked
Mother quit smoking prior to pregnancy vs. Never smoked
Mother smoked daily or occasionally during pregnancy vs. Never smoked
Days exposed to cigarette smoke in past 2 weeks during pregnancy
Week of gestation when mother quit smoking
Week of gestation when mother cut down smoking
Less than 1 cigarette smoked daily at the home during pregnancy
1−5 cigarette smoked daily at the home during pregnancy
6−10 cigarettes smoked daily at the home during pregnancy
11+ cigarettes smoked daily at the home during pregnancy
Household smoking since birth vs. None
1−5 cigarette smoked daily at the home since birth
6−10 cigarettes smoked daily at the home since birth
11+ cigarettes smoked daily at the home since birth
Partially vs. exclusively breastfed
Not breastfed vs. exclusively breastfed
Apartment/Multi−family vs. Single−Family detached home
Trailer/other vs. Single−family detached home
Household income is $50,000−99,999/year vs. <$50,000/year
Household income is $100,000−149,999/year vs. <$50,000/year
Household income is $150,000+/year vs. <$50,000/year
Household income is not disclosed vs. <$50,000/year
Father has some post−secondary education vs. Highschool or less
Father has completed post−secondary education vs. Highschool or less
Father has Masters or PhD education vs. Highschool or less















Predictor Coefficients Modelled against Cotinine
Mother did not quit smoking prior to pregnancy vs. Never smoked
Mother quit smoking prior to pregnancy vs. Never smoked
Mother smoked <5 cigarettes/day during pregnancy before quitting
Mother smoked 5−10 cigarettes/day during pregnancy before quitting
Mother smoked 11−25 cigarettes/day during pregnancy before quitting
Mother smoked daily or occasionally during pregnancy vs. Never smoked
Mother smoked <10 cigarettes/day early in pregnancy vs. None
Mother smoked 10−20 cigarettes/day early in pregnancy vs. None
Days exposed to cigarette smoke in past 2 weeks during pregnancy
Any recent tobacco smoke exposure during pregnancy
Week of gestation when mother quit smoking
Occasional household smoking during pregnancy
Regular household smoking during pregnancy
Less than 1 cigarette smok d daily at the home during pregnancy
1−5 cigarette smoked daily at the home during pregnancy
6−10 cigarettes smoked daily at the home during pregnancy
11+ cigarettes smoked daily at the home during pregnancy
Household smoking since birth
1−5 cigarette smoked daily at the home since birth
6−10 cig rettes s oked daily at the home since birth
11+ cigarettes smoked daily at the home since birth
Child's bedroom is not carpeted vs. No child−specific bedroom
Child's bedroom is carpeted vs. No child−specific bedroom
Partially vs. exclusively breastfed
Not breastfed vs. exclusively breastfed
Apartment/Multi−family vs. Single−Family detached home
Trailer/other vs. Single−family detached home
Rents vs. Owns home
Household income is $50,000−99,999/year vs. <$50,000/y ar
Household income is $100,000−149,999/year vs. <$50,000/year
Household income is $150,000+/year vs. <$50,000/year
Household income is not disclosed vs. <$50,000/year
Urine samples collected in Spring vs. Fall
Urine samples collected in Summer vs. Fall
Urine sampl s collected in Winter vs. Fall
Lives in Toronto vs. Edmonton
Lives in Vancouver vs. Edmonton
Lives in Winnipeg vs. Edmonton
Father has some post−secondary education vs. Highschool or less
Father has completed post−secondary education vs. Highschool or less
Father has Masters or PhD education vs. Highschool or less



















Figure 2.3b.  Trans-3’-Hydroxycotinine Multivariable Linear Regression Model 
Coefficients (point) and their 95% confidence intervals (line) are displayed for each variable in a 
model predicting log-transformed urinary trans-3’-hydroxycotinine concentration the prediction 
mode. Variables related to second-hand smoke are shown in red, not smoking-related variables 
in blue, and variables related to household characteristics in grey. Intervals with a point estimate 
displayed as a circle are based on bivariate analysis between each predictor and urinary trans-3’-
hydroxycotinine, while estimates displayed with a triangle reflect estimates from multivariable 
model. 
Mother did not quit smoking prior to pregnancy vs. Never smoked
Mother quit smoking prior to pregnancy vs. Never smoked
Mother smoked <5 cigarettes/day during pregnancy before quitting
Mother smoked 5−10 cigarettes/day during pregnancy before quitting
Mother smoked 11−25 cigarettes/day during pregnancy before quitting
Mother smoked daily or occasionally during pregnancy vs. Never smoked
Mother smoked <10 cigarettes/day early in pregnancy vs. None
Mother smoked 10−20 cigarettes/day early in pregnancy vs. None
Days exposed to cigarette smoke in past 2 weeks during pregnancy
Any recent tobacco smoke exposure during pregnancy
Week of gestation when mother quit smoking
Occasional household smoking during pregnancy
Regular household smoking during pregnancy
Less than 1 cigarette smoked daily at the home during pregnancy
1−5 cigarette smoked daily at the home during pregnancy
6−10 cigarettes smoked daily at the home during pregnancy
11+ cigarettes smoked daily at the home during pregnancy
Household smoking since birth
1−5 cigarette smoked daily at the home since birth
6−10 cigarettes smoked daily at the home since birth
11+ cigarettes smoked daily at the home since birth
Child's bedroom is not carpeted vs. No child−specific bedroom
Child's bedroom is carpeted vs. No child−specific bedroom
Partially vs. exclusively breastfed
Not breastfed vs. exclusively breastfed
Apartment/Multi−family vs. Single−Family detached home
Trailer/other vs. Single−family detached home
Rents vs. Owns home
Household income is $50,000−99,999/year vs. <$50,000/year
Household income is $100,000−149,999/year vs. <$50,000/year
Household income is $150,000+/year vs. <$50,000/year
Household income is not disclosed vs. <$50,000/year
Urine samples collected in Spring vs. Fall
Urine samples collected in Summer vs. Fall
Urine samples collected in Winter vs. Fall
Lives in Toronto vs. Edmonton
Lives in Vancouver vs. Edmonton
Lives in Winnipeg vs. Edmonton
Father has some post−secondary education vs. Highschool or less
Father has completed post−secondary education vs. Highschool or less
Father has Masters or PhD education vs. Highschool or less














Predictor Coefficients Modelled against 3HC
Mother did not quit smoking prior to pregnancy vs. Never smoked
Mother quit smoking prior to pregnancy vs. Never smoked
Mother smoked daily or occasionally during pregnancy vs. Never smoked
Days exposed to cigarette smoke in past 2 weeks during pregnancy
Week of gestation when mother quit smoking
Week of gestation when mother cut down smoking
Less than 1 cigarette smoked daily at the home during pregnancy
1−5 cigarette smoked daily at the home during pregnancy
6−10 cigarettes smoked daily at the home during pregnancy
11+ cigarettes smoked daily at the home during pregnancy
Household smoking since birth vs. None
1−5 cigarette smoked daily at the home since birth
6−10 cigarettes smoked daily at the home since birth
11+ cigarettes smoked daily at the home since birth
Partially vs. exclusively breastfed
Not breastfed vs. exclusively breastfed
Apartment/Multi−family vs. Single−Family detached home
Trailer/other vs. Single−family detached home
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Figure 2.4a.  Multiplicative Change in Cotinine Multivariable Linear Regression 
Model 
Multiplicative change in urinary cotinine concentration (point) and 95% confidence intervals (line) 
are displayed for each variable in the prediction model calculated using the inverse-log-
transformed coefficients. Variables related to second-hand smoke are shown in red, not smoking-
related variables in blue, and variables related to household characteristics in grey. Intervals with 
a change estimate displayed as a circle are based on bivariate analysis between each predictor 
and urinary cotinine, while estimates displayed with a triangle reflect estimates from multivariable 
model. 
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Figure 2.4b.  Multiplicative Change in trans-3’-Hydroxycotinine Multivariable 
Linear Regression Model 
Multiplicative change in urinary trans-3’-hydroxycotinine concentration (point) and 95% 
confidence intervals (line) are displayed for each variable in the prediction model calculated using 
the inverse-log-transformed coefficients. Variables related to second-hand smoke are shown in 
red, not smoking-related variables in blue, and variables related to household characteristics in 
grey. Intervals with a change estimate displayed as a circle are based on bivariate analysis 
between each predictor and urinary trans-3’-hydroxycotinine, while estimates displayed with a 
triangle reflect estimates from multivariable model.
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Figure 2.5. Measured vs. Predicted log-transformed urinary cotinine 
concentration 
Relationship between predicted and measured log-transformed urinary metabolite concentrations 
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Urinary nicotine metabolite concentrations 
Nicotine exposure was nearly ubiquitous in our study population, with nearly 90% of the 
sample having some detectable level of nicotine metabolite(s). This is similar to a 
Korean cohort study in which 88% of non-smoking homes had infants with detectable 
concentrations of cotinine (Kim & Lee, 2016), and a study of American adolescents 
which found that nearly all participants were exposed to tobacco but that the majority of 
smoking exposure in this population was primarily from light second-hand smoke (SHS) 
and third-hand smoke (THS) exposure sources (Benowitz et al., 2017). Compared to 
similar studies (Becker et al., 1999; Benowitz et al., 2017; Georg E Matt et al., 1999; 
Olivieri et al., 2006), the urinary concentrations of nicotine metabolites in our study 
sample appear to be reflective of those with low or light SHS and/or THS exposure. 3HC 
had a larger interquartile range (0.38ng/mL vs. 0.19ng/mL) than cotinine, indicating that 
it varies more in the population and may be a more sensitive biomarker of nicotine 
exposure.  
On average, the 3HC concentrations were at least twice that of the cotinine 
concentrations. This is likely due to the difference in the half-lives of nicotine and cotinine 
between infants and adults. Neonates and children under 1 year of age have lower 
nicotine metabolism rates, with a nicotine half-life three to four times longer than adults 
(Collier et al., 1994; D. Dempsey, Jacob, & Benowitz, 2000). The metabolism of cotinine 
into 3HC in neonates is similar to that of older children and adults (D. Dempsey et al., 
2000). Part of this difference may be due to initially low hepatic blood flow in the  
transition from umbilical flow (Gow, Ghabrial, Smallwood, Morgan, & Ching, 2001), and 
the use of less efficient liver enzymes to metabolize nicotine in early life (Tateishi et al., 
1997).  
Prediction Models 
Our study found that prediction models explained less than half of the variation in urinary 
biomarker concentrations. The predictive multiple linear regression models explained 
31.43% of log-transformed cotinine, and 40.89% trans-3’-hydroxycotinine (3HC) 
concentrations in our cohort study. This is slightly lower than others have been able to 
predict of urinary cotinine (33-45%) in children, though these studies have children with 
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at least one household smoker which differs from the CHILD cohort (Georg E. Matt et al., 
2000; Wong et al., 2002). Parental reports are helpful in characterizing smoke exposure, 
but less helpful when completed by non-smoking mothers (Georg E Matt et al., 1999). 
Others have had more success in predicting serum cotinine (R2 of 61%) when including 
indoor air nicotine levels, duration of exposure and ventilation measures (Kalkbrenner et 
al., 2010). Plotted measured vs. predicted concentrations show some fanning of the 
observations, particularly at higher concentrations suggesting that the residuals have 
non-constant variance and that confidence intervals and significance tests should be 
interpreted with caution. 
Our models may not better explain the variation in cotinine concentrations for a 
few reasons. The half-life of cotinine means that there will naturally be more variability 
for those with low or inconsistent exposure (Goniewicz et al., 2011). Another reason may 
be that our questionnaires are subject to reporting bias and cannot adequately detect all 
aspects of smoke exposure, namely thirdhand smoke (THS) exposure. Finally, those 
with detectable levels of cotinine and trans-3’-hydroxycotinine may be the result of 
nicotine exposures not related to tobacco smoke, such as diet (Siegmund, Leitner, & 
Pfannhauser, 1999). 
While cotinine concentrations remain a reliable way of verifying questionnaire 
reported tobacco smoking exposure in populations with some level of SHS, it is unlikely 
that biomarkers or questionnaires adequately reflect true exposure on their own. 
Prediction models created to explain small-for-gestation size in a Chinese cohort of 
pregnant women found that self-reported smoking better predicted actual smoking 
exposure than cotinine measures (Xie et al., 2015). As researchers report lower levels of 
detection, nicotine exposure in many populations becomes nearly ubiquitous and may 
begin to lose its predictive power as a proxy of tobacco smoke-related health risks.  
The model to predict 3HC contained more variables, with some of these 
additional variables related to carpeting, home ownership, and the season at collection 
of the urine samples. More influence due to suspected third-hand tobacco smoke 
reservoirs than was found in the cotinine model may exist because 3HC has a longer 
half-life and may be more sensitive to intermittent or low-level exposure sources. 
Important predictors to both models include tobacco smoke exposure to the mother 
during pregnancy and the presence of household smoking since the child’s birth.  
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Dwelling type, paternal education, income, and breastfeeding status were used in 
predicting both urinary cotinine and 3HC. Breastfeeding was likely a surrogate for other 
exposures related to tobacco exposure and explaining why those who were breastfed 
the least had the highest concentrations of urinary cotinine and 3HC. Breastfeeding went 
being associated with lower concentrations to being associated with higher 
concentrations when adjusting for other smoking factors. In a prediction model where 
collinearity and correlated predictors are present, the coefficients become less reliably 
interpretable. Sparse data bias, a problem where coefficients for levels of a variable with 
relatively few participants, likely plays a role. For these reasons, assessing the geometric 
mean concentrations within our important predictors becomes more helpful than 
consideration of the adjusted model coefficients. 
Incorporation of Machine Learning 
Random forest analysis identified exposure items relating to breastfeeding, third-hand 
sources of tobacco smoke (eg. carpeting, area rugs), and household characteristics (eg. 
single-family detached vs. other buildings) as being particularly important in predicting 
the nicotine metabolite concentrations. The advantages of using machine learning 
methods in environmental epidemiology were recently described as an intelligent way to 
assess a magnitude of potential exposures and pathways (Saglani & Custovic, 2019). 
The benefit of blended multiple linear regression-random forest (MLR-RF) models (Yuchi 
et al., 2019) was recently illustrated in particulate air pollution and may be useful for 
assessing tobacco smoke pollution as well.  
Second-hand Smoke 
Prenatal smoking exposure and related behaviours were important predictors of early life 
cotinine and 3HC concentrations. 92% of mothers reported that they never smoked. Half 
of the remaining sample of mothers quit during pregnancy. However, one-fifth of mothers 
reported some recent exposure to tobacco smoke during their pregnancy, a proportion 
closer to the 24% of mothers who had smoked at some point before or during their 
pregnancy. 7.4% of the participants reported some tobacco smoke to their child at 3 to 4 
months, and 4.4% of the sample reported that the baby had been exposed to tobacco 
smoke in the past week. Of the 183 parents that reported cigarettes smoked at the home 
daily in the child’s early life, 62% reported between 1 and 5 cigarettes smoked per day.  
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Indicators of reduced exposure 
At households where smoking had occurred, it was predominantly reported that the 
smoking happened outdoors. This behaviour limits the extent and proximity of smoking 
to the child, and so reflects that parents have some understanding of the dangers of 
smoking around an infant (eg. smoking in the garage, or outside). While 12% of our 
sample reported that someone had smoked at the home since the child’s birth. 11% of 
the sample reported that smoking occurred outside of the house, and 1.6% reported that 
smoking occurs near a window or in the garage. Only 0.5% reported smoking occurred 
inside the home. By comparison, in pregnancy the same questions reported that 11% 
had a smoker living at the home, 9% had smoking occur outside the home, with 2% near 
a window or in the garage and 1% of the sample reporting smoking takes place inside 
the home. Although the proportion of smokers in the home is similar before and after 
birth, the location of where the smoking occurs changed slightly and supports the 
hypothesis that avoidance behaviour is greater in the presence of a child than in the 
presence of a pregnant woman. Taken together, these encouraging findings illustrate 
that most people who smoke at a home with an child or expectant mother will make the 
effort to smoke outside, reducing second-hand smoke exposure.  
Socioeconomic factors 
Household income, education level, and maternal age were inversely related with the 
child’s urinary concentrations. Younger mothers tend to have less formal education, and 
are less successful in quitting smoking (Connor & McIntyre, 1999). The dwelling type of 
the home was important in both prediction models. Those living in apartments or multi-
family homes having higher urinary concentration of cotinine and 3HC. Second-hand 
smoke is a prominent issue for those in multi-family and multi-unit housing (Burton, 
2011). Children living in rented homes (23%) had higher concentrations of urinary 
cotinine and 3HC than those who owned their home. Income, education, and housing 
are all interrelated factors that influence the likelihood of a child being exposed to 
tobacco smoke in their early life. The inclusion of these variables in prediction models 
are expected to add value because they capture smoke exposure not already captured 
by the questions directly related to SHS exposure. We hypothesize that younger, less 
educated and lower income mothers are more likely to have friends who smoke or visit 
public areas where smoking occurs, which may not be reflected in SHS-related 




Third-hand smoke is a relatively novel concept, with the term first coined in the late 
2000’s (Acuff, Fristoe, Hamblen, Smith, & Chen, 2016). Third-hand smoke (THS) occurs 
when second-hand smoke (SHS) interacts with the physical environment and is heavily 
adsorbed onto surfaces and accumulates in dust,(Burton, 2011). This contamination of 
surfaces and fabrics from SHS persists to be later released into the air. Third-hand 
smoke, or residual tobacco smoke pollutants, can be re-emitted back into a gas or can 
react with environmental oxidants or other pollutants to create secondary exposures 
(Acuff et al., 2016; Burton, 2011). Building type, and household furnishings may 
contribute to tobacco smoke exposure. Predictors related to household reservoirs of 
thirdhand smoke, such as carpeting, were important in modeling 3HC, though not 
cotinine. Carpeted flooring and area rugs in the home have been shown to harbour 
tobacco combustion products (G E Matt, 2004).  
THS exposure can remain elevated for 6 months after smoking cessation, which 
is related to the number of reservoirs such as fabrics, carpets, and dust in the home 
(Bekö et al., 2018; Georg E Matt et al., 2017). Upholstery, carpets, and other fabrics 
absorb the smoke more readily than other surfaces and can off-gas its contaminants 
over longer periods of time (Gee, Semple, Watson, & Crossfield, 2013; Leung, Ho, 
Wang, & Lam, 2018; Georg E Matt et al., 2017). Therefore, even after smoking 
cessation, a home may have residual exposure. Infant’s nicotine exposure was slightly 
higher during warmer seasons than in winter in our sample. This may be related to 
people spending more time outdoors or opening windows, potentially allowing the 
infiltration of cigarette smoke into the home. The use of cigarettes has been found to 
increase during warmer months when it is more pleasant of an experience to smoke 
outdoors, likely due to indoor air restrictions (Momperousse, Delnevo, & Lewis, 2007).   
Characterizing and capturing THS remains a challenge to assessing tobacco 
smoke exposure. Questionnaires may not accurately capture the complex chemistry of 
combustion, furnishings, ventilation and human behavior. Third-hand exposure raises 
significant challenges for policy makers given the lack of human studies that consider 
this exposure (Burton, 2011; Jacob et al., 2017). Only in the past few years have 
researchers begun to tease out the effects and pervasiveness of thirdhand smoke (Hang 
et al., 2017; Leung et al., 2018; Northrup, Jacob, et al., 2016; Northrup, Matt, Hovell, 
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Khan, & Stotts, 2016). As a relatively new phenomena in public health, the public lacks 
awareness and understanding of third-hand smoke may be an important component of 
tobacco control (Díez-Izquierdo et al., 2018). 
There appears to be a lack of understanding of the far-reaching effects of 
second-hand and thirdhand smoke. Some researchers have proposed that nearly 85% 
of tobacco smoke is invisible (Gee et al., 2013). While exposure may not be odorous or 
visible, these light exposures still carry risks (Burton, 2011), thereby posing a knowledge 
translation challenge for increasing public awareness. While 11-12% of the sample 
reported that someone in the home smoked, only 7.4% reported that any child had any 
exposure to smoking in early life. This is less than the 22% we estimated to have some 
SHS exposure. Only a quarter of those who reported a household smoker also reported 
that their baby had some level of smoking exposure. Similarly, of the 223 mothers who 
reported that a smoker lived at the home during pregnancy, just 49 (22%) reported being 
exposed to smoke while at their home on an occasional (n=25), or regular basis (n=24). 
While the majority of household smoking occurred outside, there is still the potential for 
exposure through ventilation and third-hand reservoirs. These inconsistencies may be 
due to social desirability bias, or the lack of awareness of the pervasiveness of second 
and thirdhand smoking. 
Quantifiably characterizing exposure 
Density plots (Figure 2.3) show that cut-points in urinary concentrations meant to 
characterize exposure are not perfect reflections of true exposure. Similar to findings by 
Dostal et al. (Dostál et al., 2008), there was notable overlap in the distribution of the 
infants’ urinary concentrations by predictors meant to characterizing them as exposed or 
not. This makes the recommendation of cut-points for this population more difficult. We 
cautiously agree with the continued use of 0.25ng/mL of cotinine as a cut-point to 
differentiate those from some confirmed light SHS to those exposed to more intermittent 
or THS sources. For 3HC, recommend doubling the concentration used as cut-point in 
the distribution of cotinine. The use of the metabolites to characterize tobacco smoke 
exposure in infants of a population with relatively low exposure is challenged by the 
natural variability that comes with intermittent exposure, the half-life of these metabolites, 
and the potential for nicotine to be sourced from diet (Benowitz et al., 2017; Davis, Stiles, 




We acknowledge that the participants in our study may not reflect the vulnerable 
population most at-risk for tobacco smoke exposure. While the low prevalence of 
tobacco smoke exposure in this cohort should be celebrated, this cohort does slightly 
underestimate true exposure experienced by the Canadian population. The parents of 
CHILD participants are more affluent, educated, and allergic or predisposed to sensitivity 
than the general Canadian population. Mothers who smoke during pregnancy are more 
likely to be of low socioeconomic status, non-immigrants, single, have a chronic disease, 
without a family doctor, and parenting without having attended prenatal classes (Al-
Sahab et al., 2010; Cui, Shooshtari, Forget, Clara, & Cheung, 2014). As a result, our 
recommendations from this study can only be applied to populations similar to our cohort 
and may not be suitable for individuals from demographics linked to higher cigarette use. 
At the time of data collection for questionnaires used by this study, e-cigarette 
use was not yet popularized, and marijuana use was still illegal in Canada. We recognize 
that we have been unable to assess for novel, non-cigarette tools for tobacco exposure, 
and encourage that future analysis make use of data on marijuana and e-cigarette use 




2.7. Conclusion and Future Directions 
Our results suggest that tobacco smoke questionnaire models may not accurately 
explain the majority of variation in cotinine nor trans-3’-hydroxycotinine concentrations 
within a population with relatively little smoking exposure. Questionnaires are a flexible 
and relatively inexpensive method of assessing exposure, but biomarkers of tobacco 
smoke exposure are considered as more accurate and can be obtained with little burden 
to the subject. However, cotinine alone is not a suitable measure of tobacco smoke 
exposure. Questions that best explained the variation in nicotine metabolite 
concentrations included whether the mother quit smoking prior to pregnancy, the number 
of cigarettes smoked daily at the home during pregnancy, and the presence of 
household smoking since the child’s birth. Tobacco smoke exposure models could use a 
combination of questionnaire and biomarker data to more accurately assess risk or 
consider other exposure assessment tools. Researchers need to be aware of the context 
of their sample population and be purposeful in the selection of the appropriate exposure 
measures. The ability of machine learning approaches, such as random forest 
regression to enhance modeling research makes it a new tool for exploring exposure in 
environmental health. While our smoking rates were low and parents appear to be 
motivated to avoid exposing the child to smoke, nicotine exposure was nearly 
ubiquitous. 
As the Canadian population overall is reducing the rates of smoking, particularly 
during pregnancy and when around children – both as a result of policy and social 
pressures, our understanding of cotinine as a measure of smoking needs to change. 
With growing public health concern over e-cigarettes and marijuana smoking, this study 
highlights a lack of awareness of light second-hand and thirdhand smoke as an 
additional frontier of tobacco smoke research and action. Future work should focus on 
collaboration between qualitative and quantitative analysis to better understand the 
motivations behind reducing smoking exposure to children, cessation, and how the 
implications of second-hand smoke are understood by the public. The potential for 
dietary nicotine exposure to an infant, particularly in populations with low reported 
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3.1. Abstract 
Introduction 
Accurately assessing tobacco smoke exposure in early life is important to understanding 
and preventing childhood asthma. As levels of detection for nicotine metabolites, 
cotinine and trans-3’-hydroxycotinine (3HC) fall, re-examination of these markers in 
settings of light tobacco smoke exposure is needed. In addition to second and thirdhand 
smoke, breast milk provides an additional route of exposure to smoke and dietary 
sources of nicotine, complicating our interpretation of these biomarkers concentrations 




Using data from 1,432 infants from the CHILD Cohort Study, urinary concentrations of 
cotinine and 3HC collected at 3-4 months of age were compared by breastfeeding, 
maternal diet, and a number of other factors in relation to reported tobacco smoke 
exposure.  Logistic regression models were used to assess the relationship between 
urinary concentrations of cotinine and 3HC and multiple asthma-related health outcomes 
at 3 and 5 years of age. This relationship was compared to consideration of 
questionnaire responses to explain asthma and related risk. The ability for maternal diet 
high in vegetables to influence these infants' urinary cotinine and 3HC concentrations 
was assessed using bivariate and multivariable linear regression (MLR) models and 
likelihood ratio tests. 
Results 
Cotinine and 3HC levels were associated with a greater odds of recurrent wheeze at 1 
and 5 years of age, but not helpful in predicting other outcomes related to allergic and 
asthmatic disease in childhood. The 62% of infants who were exclusively breastfed had 
the lowest prevalence of reported second-hand smoke exposure and the lowest urinary 
concentrations of cotinine and 3HC. MLR models found that exclusively breastfeeding 
only increased the infant’s nicotine exposure only if the mother smoked while she was 
pregnant. The presence of a household smoker was associated with higher 
concentrations of nicotine metabolites in infants, independent of the infant’s 
breastfeeding status. A maternal diet high in vegetables assumed to contain nicotine 
was not associated with their infant’s urinary cotinine nor 3HC concentrations. 
Conclusions 
When the mother is a smoker, breastfeeding increases nicotine exposure to the child. 
Breastfeeding does not appear to affect infant exposure when the mother is not a 
smoker, likely because the majority of household smoking occurs outdoors. Mothers that 
breastfeed should be encouraged to reduce or quit smoking and maintain breastfeeding 
rather than reduce or quit breastfeeding and continue smoking. Dietary sources of 
nicotine from the mother did not influence the child’s urinary concentrations or their risk 




Assessment of early life exposures is important to understanding the gene-environment 
interactions that take place during this vulnerable window of development, and for the 
development of preventative measures to improve health outcomes. The problematic 
long-term health and economic burden has motivated investigations of environmental 
predictors of the illness to better diagnose, manage or predict asthma risk (Ismaila, 
Sayani, Marin, & Su, 2013; Subbarao et al., 2015). Comprehensive longitudinal cohort 
studies provide invaluable information about complex risk factors, pathways and 
exposure and/or developmental interactions that help to explain the development and 
persistence of asthma (Radhakrishnan et al., 2014; Sears, 2014). 
Accurately assessing tobacco smoke exposure in early life is important in 
understanding and preventing the development of childhood asthma and wheeze 
(Silvestri, Franchi, Pistorio, Petecchia, & Rusconi, 2015). Questionnaires are a flexible 
and relatively inexpensive method of assessing exposure, but biomarkers of tobacco 
smoke exposure are regarded as more accurate measures and can be obtained with 
little burden to the subject. When a cigarette is smoked, over 5000 components are 
released, many of which are carcinogenic and toxic but only a fraction can be measured 
and linked with health outcomes (Talhout et al., 2011). Nicotine is a key component of 
tobacco smoke, which can be easily traced in human subjects using biomarkers. While 
there are many testable metabolites of nicotine, cotinine is the most widely used 
biomarker of tobacco smoke exposure. However, studies in recent years using tests with 
low levels of detection have found that while high concentrations of cotinine reliably 
predict second-hand smoke exposure, the ubiquity at low levels of exposure (typically 
reflecting light second-hand or thirdhand smoke) have not been clinically useful for 
predicting asthma risk (Benowitz et al., 2017). 
Previous research has found that most subjects in the CHILD cohort study have 
very low tobacco smoke exposure, and that the majority of reported exposure to the 
infant is light second-hand smoke, or third-hand smoke (Chapter 2). Questionnaire-
based predictive models have only been able to explain 31% and 41% of the variation of 
cotinine and trans-3’-hydroxycotinine concentrations (Chapter 2). The same predictive 
models found the infant’s breastfeeding status to be important to the fit of the models, 
warranting further investigation.  
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Clinical significance in low-exposure settings 
A recent study found that cotinine is nearly ubiquitous in the urine of their adolescent 
population, and that the clinical significance of ‘light’ exposure (less than second-hand 
exposure) needs further research (Benowitz et al., 2017). It has been proposed by other 
studies that the clinical impacts of light second-hand or third-hand smoke are minimal 
but require further consideration (Northrup et al., 2016). Cotinine is a good way of 
distinguishing between active and passive smoke exposure (Goniewicz et al., 2011), but 
is less helpful in populations of infants where the only form of tobacco smoke exposure 
is passive second-hand and third-hand. Third-hand smoke occurs when second-hand 
smoke (SHS) adsorbed onto surfaces and reservoirs such as carpeting an upholstery, or 
accumulates in dust to be re-emitted over time, long after the initial smoking event 
(Burton, 2011). Tobacco smoke experts have suggested that the once-dismissed source 
of dietary nicotine through certain vegetables may now be relevant in populations with 
very little tobacco smoke exposure (Hovell et al., 2000). The benefit of cotinine as a 
marker of risk in a setting of light tobacco smoke exposure has been brought into 
question (Benowitz et al., 2017; Hovell, Zakarian, Wahlgren, Matt, & Emmons, 2000; 
Jacob et al., 2017). This work will analyze and discuss the use of urinary cotinine and 
3HC to explain asthma risk and explain why this approach may be problematic in a 
population with relatively light tobacco smoke exposure. The work presented sources 
data from the Canadian Healthy Infant Longitudinal Development (CHILD) Study.  
Implications of dietary sources of nicotine exposure 
This study considers dietary sources of nicotine intake for infants, with 
implications both for breastfeeding recommendations as well as the use of common 
biomarkers in the context of low-level tobacco smoke exposure. People can be exposed 
to nicotine through inhalation, ingestion, and skin exposure. Tobacco plants produce 
nicotine naturally as a botanical insecticide (Benowitz, Hukkanen, Jacob, & III, 2009), 
and can also absorb it through contaminated soil and air (Selmar et al., 2015). Nicotine 
concentrations in these plants may differ by species and where their crop is grown, with 
nicotine often more concentrated in the skin of vegetables (Siegmund, Leitner, & 
Pfannhauser, 1999). If ingested, this circulating nicotine may be passed to a 
breastfeeding infant before it is further metabolized or excreted by the mother. 
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In health research, we tend to focus on the inhalation exposure route as the most 
prevalent as it relates to respiratory and cardiovascular disease, among others. Some 
studies have used cotinine as the sole measure of a subjects’ tobacco smoke exposure 
(Duby et al., 2015). This is a problematic approach when studying a population that may 
be exposed through ingestion and skin, and whose primary source of nicotine is not 
tobacco smoke but rather diet or household contact with reservoirs of smoke products 
(eg. carpeting). Nicotine can be passed from mother to child through breast milk (Becker 
et al., 1999), and that breastfeeding status helps to predict urinary cotinine and 3HC 
concentrations (Chapter 2). Though it is usually assumed that all nicotine passed 
through breast milk originates from maternal exposure to tobacco smoke, it is possible 
that some of this nicotine comes from diet or other exposures.  
Nightshade vegetables such as eggplant, peppers, potatoes and tomatoes 
contain small but detectable levels of nicotine (Benowitz et al., 2017; Davis, Stiles, 
DeBethizy, & Reynolds, 1991; Sheen, 1988; Siegmund et al., 1999). The amount of 
nicotine that accumulates in the body from these dietary sources is comparable to that of 
a person exposed to tobacco smoke through third-hand exposure, with an estimated 
mean daily intake of 1.4 ug/day (Siegmund et al., 1999).  One food toxicology study 
found tomatoes to have an average nicotine concentration of 7.3 ng/g, and potatoes had 
an average concentration of 15 ng/g wet weight (Davis et al., 1991).  
Cotinine from dietary sources of nicotine are lower than concentrations measured 
in those with moderate second-hand smoke exposure, but the context of smoking 
exposure and cut-points used to measure smoking exposure with biomarkers has 
changed (Benowitz et al., 2009). If an infant's urinary concentration of nicotine 
metabolites is the result of a maternal diet high in nicotine-containing vegetables, our 
understanding of these concentrations as an indicator of smoke-related asthma risk 
needs to change. The potential for this situation is relevant in populations where 
smoking exposure is low and vegetable access is relatively high and encouraged during 
pregnancy and a child’s early life. 
Some researchers suggest that nicotine from diet is not clinically relevant and it 
will not confound interpretation of cotinine concentration as the sole measure of passive 
smoking exposure (Bramer & Kallungal, 2003; Repace, 1994). This argument may have 
been valid in a population primarily exposed to first-hand and heavy second-hand 
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exposure, the concept has not been explored with tests using very low levels of 
concentration detection or in a population with infrequent and low levels of tobacco 
smoke exposure. If nicotine metabolites are found to be sourced from vegetable intake, 
there is a potential for the anti-oxidant effects of vegetables to balance oxidizing effects 
of any tobacco smoke products and other stressors linked to asthma, minimizing or 
actually reducing the risk of asthma and allergic disease (Papadopoulou et al., 2015; 
Sordillo et al., 2019). 
Objectives 
The objectives of this project were to; 
1) Assess the relationship between nicotine metabolite concentrations in 
infants and respiratory and allergic health risks in childhood. 
2) Explore whether infant diet may help to predict variation in cotinine 
and 3HC concentrations amongst our study sample. 
3) To determine if a maternal diet high in vegetables is associated with 
higher levels of cotinine in breastfeeding infants, and how this affects 




This study made use of secondary data provided by the CHILD cohort study. Data was 
collected using a combination of questionnaires, clinical assessments (clinician visits; 
outcome phenotyping), home visits, and biological samples (urine samples). CHILD is 
the largest longitudinal birth cohort study in Canada, with 3455 children were recruited 
from largely-urban centers in 4 provinces across Canada (Vancouver, BC; Edmonton, 
AB; Winnipeg, Morden, and Winkler, MB; and Toronto, ON) that reflect the general urban 
Canadian population (Takaro et al., 2015). At age 5, over 90% of the original families are 
still enrolled in the study. CHILD is well-positions to add valuable knowledge to tobacco 
smoke exposure science for three main reasons: 1) The assay used is very sensitive 
with a relatively low level of detection (0.03ng/mL), 2) The population is young 
(participants recruited at birth, mean age of mothers is 32 years), and 3) There is a 
relatively low prevalence of reported smoking in the cohort (5% of mothers smoking 
before pregnancy, 3% continued to smoke during pregnancy). While the cohort is 
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ongoing, data used for this project was collected between 2008-2017. A dataset of 1,432 
participants had complete data on our biomarkers of nicotine exposure, health 
outcomes, food frequency questionnaires, and other home environment and lifestyle 
questionnaires relating to tobacco smoke exposure (Appendix A: Sample Selection Flow 
Chart). 
Biomarker collection 
Urine samples were collected by trained research assistants at the 3-month follow-up 
home visits. The procedure for the collection of the samples has been previously 
outlined by the CHILD study (Takaro et al., 2015). Samples were then analyzed for 
cotinine and trans-3’-hydroxycotinine (3HC) at the Centers for Disease Control and 
Prevention's Tobacco Laboratory in Atlanta, GA. Samples were first hydrolyzed using β-
glucuronidase to de-conjugate any glucoronidated cotinine and 3HC molecules. After 
extraction, the samples were analyzed by liquid chromatography-atmospheric pressure 
chemical ionization tandem mass spectrometry (LC-APCI-MS-MS) (Kato, Silva, 
Needham, & Calafat, 2005; Takaro et al., 2015). Analyte concentrations were calculated 
using least-squares linear regression of the peak area ratios of native to internal 
standards. The limit of detection for both cotinine and trans-3'-hydroxycotinine was 0.030 
ng/mL. To account for dilution of the urine samples, biomarker concentrations were 
corrected for specific gravity measurements collected at the time of sample collection as 
previously described (Chapter 2). Concentrations below the level of detection were 
imputed using a truncated method (Lubin et al., 2004).  
Demographics, Tobacco Smoke, and Diet Variables 
Demographics and other variables relating to household or second-hand smoke 
exposure were determined using a combination of home environment questionnaires, 
home assessments, parent-completed health, socioeconomic and environment 
questionnaires. 
Breastfeeding status was determined using a questionnaire completed when the 
child was approximately 3-4 months of age. Parents reported whether the child had 
exclusively been breastfed, partially breastfed, or never breastfed. A separate question 
gathered details of the infant's diet, distilled with 6 combinations of exposure breastmilk, 
formula, and the introduction of solid foods. 
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A food frequency questionnaire was given to mothers for completion during 
pregnancy (Fred Hutchinson Cancer Research Center, n.d.). Using these responses, a 
daily average vegetable intake score was calculated. Additionally, a prudent/healthy diet 
score was calculated using loading scores from principal components analysis that 
reflects how well a participant adhered to a specific type of diet, as previously described 
(de Souza et al., 2016). For those with a higher prudent/healthy diet score, vegetable 
intake was high and the intake of pizza and fried foods was very low. Nutritional 
epidemiology has moved beyond measuring intake of specific foods to using food 
pattern analysis, usually in the form of principle components analysis to improve 
estimates of dietary characterization in health research (Hu, 2002; Lioret et al., 2015; 
Robinson et al., 2007). The average frequency of nicotine intake was calculated based 
on existing literature on the nicotine content of certain foods, our food frequency 
questionnaires, and Health Canada portion size guidelines (Appendix B). Each of these 
dietary vegetable or nicotine intake during pregnancy variables were compared to the 
infant’s urinary cotinine and 3HC concentrations in early life. 
Modeling health outcomes 
For analysis of health outcomes at 1, 3 and 5 years of age, bivariate logistic regression 
models were used. CHILD has health outcome data from questionnaires completed by 
parents, questionnaires completed by clinicians at a clinical assessment, and results 
from skin prick tests for allergic sensitivity. The health outcomes considered in this study 
were atopy, recurrent wheeze, and asthma, with their meaning and characterization 
detailed below.  
• Atopy: Atopy was determined by skin prick tests previously described for this 
cohort (Tran et al., 2018). The child had atopy if they had a 2mm wheal 
response to at least of the common allergens tested. Skin prick tests were 
completed at 1, 3, and 5 year clinical visits. Allergens tested at 1 year included 
6 inhalant allergens (Alternaria tenuis fungus, cat hair, dog epithelium, house 
dust mites Dermatophagoides pteronyssinus and D. farina, and german 
cockroach), and four food allergens (whole cow’s milk, egg white, soybean, 
and peanuts). At 3 and 5 years of age, the same 4 food allergens, along with 
13 inhalant allergens (Alternaria tenuis, cat hair, dog epithelium, house dust 
mites Dermatophagoides pteronyssinus and D. farina, grass, mid-west trees, 
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ragweed, weeds, cladosporium, penicillium, Aspergillus fumigatus, and 
German cockroach) were tested.  
• Recurrent Wheeze: Recurrent wheeze has been defined by the CHILD study 
as “two or more episodes of wheeze in one year”, as derived by CHILD based 
on the follow-up questionnaire item: “If yes [to wheeze], how many episodes?”. 
The original question for the child health questionnaire was “In the last 
(specified time period), has your child had a wheezing noise (whistling sound) 
coming from his/her chest either with a cold or without a cold?”. An episode 
was defined as wheezing for at least 15 minutes at a time with episodes 
separated from each other by at least 7 days. Episodes that were within a 
week of each other were classified as one continuous episode. Wheezing 
episodes reported upon a clinical visit or reason for separate hospital visit 
were also considered. 
• Asthma Diagnosis: While diagnosing a child with asthma at a young age is 
difficult and inconsistent over time, this outcome between three and five years 
of age is widely used by researchers. Asthma was defined using the 
questionnaire completed at each clinical assessment by a trained clinician. 
When asked “In your opinion, does this child have asthma?.”, they had 
response options of “No”, “Possible” and “Yes/Probable”. Those classified as 
“Possible” or “Probable” qualified as a suspected asthma case in this study.  
Logistic regression models were used to assess the relationship between the log-
transformed urinary concentrations in a continuous form against each of the health 
outcomes at 1, 3 and 5 years of age. The same analysis was then completed after 
stratifying the sample by breastfeeding status at 3-4 months of age (Exclusive, Partial, 
None). Subjects were then categorized by splitting the continuous distribution of each 
biomarker into two groups based on thresholds that reflect some second-hand smoke 
exposure (see Chapter 2). For cotinine, those at or above 0.25 ng/mL were considered 
to have some second-hand smoke exposure (Benowitz et al., 2017)(Chapter 2). Those 
with at least 0.50 ng/mL of 3HC were considered to have some level of second-hand 
smoke exposure. The logistic modeling process was then repeated using these binary 
exposure variables. To determine whether questionnaires do as good or better of a job 
at predicting asthma risk, the relationship between urinary cotinine and 3HC 
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concentrations and health outcomes was then compared to the relationship between 
questionnaire responses related to smoking and the same health outcomes. These 
questionnaire items pertained to whether the mother had quit smoking prior to 
pregnancy, whether household smoking had occurred since the child’s birth, and how 
many days the mother was exposed in past two weeks of pregnancy. 
Exploring the link between breastfeeding and nicotine metabolite concentrations 
Geometric mean concentration of cotinine and trans-3’-hydroxycotinine were calculated 
for the overall sample, as well as for each level of selected questionnaire-reported 
variables, such as breastfeeding. Analysis of variance (ANOVA) tests were used to 
determine whether the mean concentration of these biomarkers differed significantly by 
level of breastfeeding exposure to the infant at 3 months of age (exclusive, partial, or not 
breastfed). Linear regression models were used to determine the relationship between 
breastfeeding and urinary concentrations. These models were then adjusted for 
maternal smoking status in pregnancy, then by a variable reflecting whether or not a 
smoker lived at the infant’s home in early life. Regression coefficients and significance p-
values were compared before and after adjustment to make interpretations about the 
true contribution of breastfeeding to an infant’s nicotine intake. Plots were also used to 
assess whether the child’s differing exposure by maternal smoking and household 
smoker presence was influenced by the child’s breastfeeding status. 
Exploring the link between vegetable intake and nicotine metabolite 
concentrations in breastfed infants 
Bivariate linear regression analysis was used to determine whether a high-vegetable 
maternal diet or a maternal ‘healthy’ diet score (de Souza et al., 2016) was associated 
with the infant’s urinary cotinine or 3HC concentration. This was completed using the 
overall sample, then within subsets based on breastfeeding status. We hypothesize that 
if a maternal diet that contains nicotine influences their infant’s exposure, it would be 
through breastmilk and therefore any such findings would be pronounced within the 
subset of infants who were exclusively breastfed. 
These maternal diet variables were added to existing multivariable prediction 
models described in Chapter 2 to determine whether they added predictive value when 
explaining the variation in urinary concentrations of cotinine and 3HC. This was done for 
the entire sample, as well as for a subset of infants who had been exclusively breastfed 
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in early life. Likelihood ratio tests were used, and the directionality and significance of 
these added variables in the full model were assessed. 
Using food frequency questionnaire data, we were able to see at what frequency 
the mothers ate certain foods, some of which are expected to contain small amounts of 
nicotine. Using data on foods that have been found by previous studies (Davis et al., 
1991; Sheen, 1988; Siegmund et al., 1999) to contain measurable amounts of nicotine, 
the weekly maternal intake of dietary nicotine was calculated for mothers in our sample 
of the CHILD study. These foods include raw tomatoes, tomato sauce, mashed potatoes, 
fried potatoes, ketchup, peppers, cauliflower and tea. The average reported nicotine 
concentration per gram (wet weight) was multiplied by the average number of grams in a 
single portion of that same food type, using portion sizes provided by Health Canada. 
This expected nicotine concentration per portion was then multiplied by the mothers 
reported portion size and by the number of times per week the mother reportedly at that 
food type. This continuous concentration (ng nicotine/week) of dietary nicotine in the 
mother was then analyzed against their infant’s urinary cotinine and 3HC concentration 
to determine whether an association existed. This analysis was completed for the overall 
sample, as well as a subsample of infants who had a urinary concentration of cotinine 
less than 0.25ng/mL, were exclusively breastfed, had mother who never smoked, and 
had no reported household smoking exposure in early life (n=555). This subset was of 
particular interest because it is at these low concentrations with no reported smoke 
exposure and active breastfeeding that dietary sources of nicotine may become relevant 
in contributing to an infant’s nicotine metabolite concentration.  
Analysis was completed using RStudio (R version 3.5.1 (2018-07-02)).	Ethics approval 
was obtained through Simon Fraser University, deeming this project to be a minimal risk 
study (project number 2018s0608). 
3.4. Results 
Sample demographics 
Of our final sample size of 1,432 (see Appendix B), 75% had detectable cotinine and 
89% had detectable trans-3’-hydroxycotinine (3HC) levels. After correcting for urine 
dilution and imputing those below the limit of detection, geometric mean concentration of 
cotinine was 0.11 ng/mL (95% CI; 0.11-0.12), while 3HC had a geometric mean of 0.21 
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ng/mL (95% CI; 0.20-0.23) (Table 3.1). Using 0.25ng/mL and 0.50 ng/mL as thresholds 
of cotinine and 3HC to characterize a participant as having some second-hand smoke 
(SHS) or thirdhand smoke (THS), 22-23% of our sample likely had some SHS or THS 
exposure (n=325 for Cotinine and 320 for 3HC). 
Table 3.1. Summary statistics of each metabolite 
 Summary Statistics  
Metabolite 10th % 25th % Median Mean 75th % 90th % SD Geometric 
mean 
Cotinine* 0.02 0.04 0.08 1.99 0.22 0.75 15.40 0.11 (0.11-0.12) 
3HC* 0.04 0.07 0.15 7.30 0.43 1.66 78.16 0.21 (0.20-0.23) 
*Corrected for specific gravity and with concentrations imputed below the level of detection. Cotinine and 3HC are 
measured in units of ng/mL. % = percentile of distribution, SD=standard deviation 
In our sample (n=1,432), more than half had a household income over 
$100,000/year, lived in a single-family home, 21% lived in a rented home, and 34% had 
at least one parent with a history or current diagnosis of asthma. More than 60% of 
mothers in our sample were over 30 years of age (mean age of 32 years), 5% were 
smokers before their pregnancy, 3% reported some smoking during their pregnancy and 
less than 2% reported actively smoking during their pregnancy. 62% of mothers were 
exclusively breastfeeding their child at 3 months of age, while 26% were partially 
breastfeeding, and 12% reported never breastfeeding their child. Of those who were 
partially breastfeeding their child, the majority were incorporating formula into the child's 
diet. Only 11% reported that smoking had occurred at the home since the child’s birth, 
most of this household smoking occurring outdoors. Participants from Manitoba 
(Winnipeg, Morden, and Winkler) made up the largest proportion of our sample (35%), 




Table 3.2. Sample Demographics 
Characteristic % (N) Geometric mean urinary 
Cotinine (95% CI), ng/mL 
Geometric mean urinary 
Hydroxycotinine (95% CI), 
ng/mL 
Breastfeeding Status p=0.03 p=0.06 
None 12.1 (173) 0.16 (0.12-0.20) 0.28 (0.21-0.37) 
Partial 25.8 (369) 0.11 (0.09-0.13) 0.22 (0.18-0.26) 
Exclusive 62.2 (890) 0.11 (0.10-0.12) 0.20 (0.18-0.22) 
Infant’s 3-month Diet p=0.16 p=0.26 
Breastfeeding Only 62.2% (890) 0.11 (0.10-0.12) 0.20 (0.18-0.22) 
Breastfeeding and Formula 24.2% (344) 0.11 (0.09-0.13) 0.22 (0.18-0.27) 
Breastfeeding and Solid Food 0.9% (n=13) 0.08 (0.03-0.21) 0.20 (0.07-0.57) 
Formula Only 11.2% (n=163) 0.15 (0.12-0.20) 0.27 (0.20-0.36) 
Formula and Solid Food 0.8% (n=10) 0.19 (0.05-0.76) 0.47 (0.10-2.12) 
Breastfeeding, Formula, and 
Solid Food 
0.6% (n=12) 0.12 (0.05-0.30) 0.23 (0.07-0.78) 
Centre p=0.03 p<0.001 
Vancouver 29.6 (424) 0.11 (0.09-0.13) 0.15 (0.13-0.18) 
Edmonton 19.1 (274) 0.13 (0.11-0.16) 0.28 (0.22-0.35) 
Winnipeg, Morden, and 
Winkler 
34.7 (497) 0.12 (0.11-0.14) 0.25 (0.22-0.29) 
Toronto 16.6 (237) 0.09 (0.08-0.11) 0.21 (0.17-0.25) 
Household Income p<0.01 p<0.01 
$0-49,999/year 9.2 (132) 0.26 (0.19-0.36) 0.51 (0.36-0.71) 
$50,000-99,999/year 32.3 (463) 0.14 (0.12-0.16) 0.24 (0.21-0.28) 
$100,000-149,999/year 27.7 (396) 0.10 (0.08-0.11) 0.19 (0.16-0.22) 
$150,000+/year 21.9 (314) 0.08 (0.07-0.09) 0.13 (0.11-0.15) 
Prefers to not say 8.9 (127) 0.12 (0.09-0.15) 0.28 (0.21-0.39) 
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Characteristic % (N) Geometric mean urinary 
Cotinine (95% CI), ng/mL 
Geometric mean urinary 
Hydroxycotinine (95% CI), 
ng/mL 
Maternal Age at Enrolment p<0.01 p<0.01 
17 to 23 years old 3.3 (47) 0.40 (0.25-0.65) 0.83 (0.46-1.47) 
24 to 30 years old 33.5 (480) 0.14 (0.12-0.16) 0.27 (0.23-0.31) 
31 to 35 years old 41.3 (592) 0.10 (0.09-0.11) 0.18 (0.16-0.21) 
36-46 years old 21.9 (313) 0.09 (0.08-0.11) 0.17 (0.15-0.21) 
Child’s Sex p=0.86 p=0.26 
Male 53.1 (760) 0.11 (0.10-0.13) 0.20 (0.18-0.23) 
Female 46.9 (672) 0.12 (0.10-0.13) 0.23 (0.20-0.26) 
Parental Asthma p=0.12 p=0.50 
No 66.0 (945) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Yes 34.0 (487) 0.13 (0.11-0.14) 0.22 (0.19-0.26) 
Home Ownership p<0.01 p<0.01 
Rents 21.4 (307) 0.19 (0.16-0.23) 0.34 (0.28-0.42) 
Owns 78.6 (1125) 0.10 (0.09-0.11) 0.19 (0.17-0.21) 
Household Smoker, Early Life p<0.01 p<0.01 
Yes 11.4 (163) 0.47 (0.33-0.65) 1.28 (0.89-1.84) 
No 88.6 (1269) 0.10 (0.09-0.10) 0.17 (0.16-0.18) 
Where smoking occurs at the home in early life 
Outside vs. not p<0.01 
Near Window vs. not p<0.01 
Indoors vs. not p<0.01 
Outside vs. not p<0.01 
Near Window vs. not p<0.01 
Indoors vs. not p<0.01 
Outside 10.7 (153) 0.43 (0.30-0.60) 1.19 (0.81-1.73) 
Near window or in garage 1.3 (18) 1.09 (0.39-3.01) 3.22 (1.04-9.98) 
Indoors 0.4 (6) 1.51 (0.31-7.31) 4.10 (0.98-17.12) 
Mother’s Smoking Frequency in Pregnancy p<0.01 p<0.01 
Daily or Occasionally 1.5 (22) 10.44 (4.52-24.14) 31.53 (11.73-84.75) 
Never 98.5 (1410) 0.11 (0.10-0.12) 0.20 (0.18-0.21) 
The proportion and crude number of sample subjects that corresponds to each level of household characteristic 
variables is reported to the nearest whole number. The geometric mean (95% Confidence interval) of the corrected and 
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log-transformed Cotinine distribution for each level of each variable is also shown. P-values indicate whether the 
difference in log-transformed means was statistically significant (p<0.05) amongst the variable levels based on ANOVA 
tests. 
Table 3.3. Geometric mean cotinine and trans-3’-hydroxycotinine 
concentrations by asthma, atopy, and recurrent wheeze outcomes at 
1, 3 and 5 years of age  
Health Status Cotinine 
GM* (95% CI) 
3’-Hydroxycotinine 
GM* (95% CI) 
1 year of age   
No Recurrent Wheeze (n=1319, 92.1%) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Recurrent Wheeze (n=113, 8.3%) 0.18 (0.12-0.25) 0.31 (0.22-0.47) 
No Atopy (n=1244, 86.9%) 0.12 (0.11-0.13) 0.22 (0.20-0.25) 
Atopy (n=188, 13.1%) 0.09 (0.07-0.12) 0.16 (0.13-0.20) 
No Asthma (n=1425, 99.5%) 0.11 (0.11-0.12) 0.21 (0.20-0.23) 
Asthma (n=7, 0.5%) 0.11 (0.03-0.40) 0.16 (0.04-0.74) 
3 years of age   
No Recurrent Wheeze (n=1309, 91.4%) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Recurrent Wheeze (n=123, 8.6%) 0.13 (0.09-0.18) 0.25 (0.18-0.35) 
No Atopy (n=1214, 84.8%) 0.12 (0.11-0.13) 0.22 (0.20-0.25) 
Atopy (n=218, 15.2%) 0.10 (0.08-0.12) 0.17 (0.14-0.21) 
No Asthma (n=1255, 87.6%) 0.11 (0.10-0.13) 0.21 (0.20-0.24) 
Asthma (n=177, 12.4%) 0.11 (0.09-0.14) 0.21 (0.17-0.27) 
5 years of age   
No Recurrent Wheeze (n=1336, 93.2%) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Recurrent Wheeze (n=96, 6.7%) 0.17 (0.12-0.24) 0.31 (0.21-0.48) 
No Atopy (n=1151, 80.4%) 0.12 (0.11-0.13) 0.22 (0.20-0.25) 
Atopy (n=281, 19.6%) 0.10 (0.09-0.12) 0.18 (0.15-0.22) 
No Asthma (n=1211, 84.6%) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Asthma (n=221, 15.4%) 0.13 (0.10-0.16) 0.25 (0.20-0.33) 
Geometric mean concentrations of infant’s urinary cotinine and trans-3’-hydroxycotinine are reported based on their 
health status as later characterized at 1, 3, and 5 years of age. 
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Modeling childhood asthmatic disease 
Of our sample of 1,432 participants, 325 infants (22%) were considered to be 
SHS/THS-exposed based on their cotinine concentration, while 320 (23%) were 
considered to be SHS/THS-exposed based on their 3HC concentration. The proportion 
of participants who developed recurrent wheeze was 8.3% (n=113) at one year, 8.6% 
(n=123) at 3 years, and 6.7% (n=96) at 5 years of age. The proportion of participants 
with atopy was 13.1% (n=188) at one year, 15.2% (n=218) at 3 years, and 19.6% 
(n=281) at 5 years of age. The proportion of participants with a possible or probable 
asthma diagnosis at one year of age was 0.5% (n=7). At 3 years of age, 6.7% (n=96) of 
participants had possible and 5.7% (81) had probable asthma. At 5 years of age, 7.9% 
(n=113) of participants had possible and 7.5% (n=108) had probable asthma. 
Bivariate logistic regression analysis found that log-transformed cotinine and 3HC 
concentrations were associated with recurrent wheeze at 1 and 5 years, but not at 3 
years (Table 3.3). Nicotine metabolite concentrations were negatively associated with 
atopy at 1 and 3 years of age, but not at 5 years of age (Table 3.3).  No significant 
associations were found between cotinine nor 3HC and a possible or probable asthma 





Table 3.4. Cotinine and trans-3’-hydroxycotinine as a continuous predictor of 
childhood asthma & intermediates at 1, 3 and 5 years of age vs. 
questionnaire-derived smoking predictors 
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OR (95% CI),  
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pregnancy vs. Never Smoked 
0.98 (0.58-1.58), 
p=0.94 
 0.72 (0.46-1.08), 
p=0.13 
- 
Mother smoked into pregnancy 
vs. Never Smoked 





Any household smoking in early 






Days mom was exposed in past 






 Health Outcomes at 3 years of age 












Mother quit smoking prior to 







Mother smoked into pregnancy 







Any household smoking in early 







Days mom was exposed in past 
two weeks of pregnancy 






 Health Outcomes at 5 years of age 














 Recurrent Wheeze 
OR (95% CI),  
p-value 
Atopy 




OR (95% CI), 
 p-value 
Mother quit smoking prior to 







Mother smoked into pregnancy 







Any household smoking in early 







Days mom was exposed in past 







Subset of those exclusively breastfed (n=890) 
 Recurrent Wheeze 
OR (95% CI),  
p-value 
Atopy 




OR (95% CI),  
p-value 
 Health Outcomes at 1 year of age 










 Health Outcomes at 3 years of age 












 Health Outcomes at 5 years of age 












Urinary concentrations were log-transformed and treated as a continuous variable in these bivariate logistic regression 
models against each health outcome. Results could not be generated for asthma at 1 year of age due to a low number 
of cases (n=7). Odds ratios (OR) and 95% confidence intervals (95% CI) from logistic regression models are reported. 
P-values less than or equal to 0.05 are bolded. OR are expressed per 1-unit increase in log-transformed (base 2) 




Table 3.5. Cotinine and trans-3’-hydroxycotinine as a categorical predictor of 
childhood asthma & intermediates at 1, 3 and 5 years of age  
 Recurrent Wheeze 
OR (95% CI), p-value 
Atopy 
OR (95% CI), p-value 
Asthma Diagnosis 
OR (95% CI), p-
value 
 Health Outcomes at 1 year of age 












 Health Outcomes at 3 years of age 














 Health Outcomes at 5 years of age 














Urinary concentrations were log-transformed and treated as a categorical variable, with those considered to have a 
concentration indicative of secondhand smoke (SHS) exposure compared to those with lower concentrations. Results 
could not be generated for asthma at 1 year of age due to a low number of cases (n=7). Odds ratios (OR) and 95% 
confidence intervals (95% CI) from logistic regression models are reported. OR are expressed per comparing higher 
(>=0.25 ng/ml) with lower cotinine (<0.25 ng/ml) and higher (>=0.50 ng/ml) with lower 3HC (<0.50 ng/ml) concentration. 
P-values less than or equal to 0.05 are bolded. The range of the log-transformed cotinine concentration was from -





Table 3.6. Multiplicative change in cotinine and trans-3’-hydroxycotinine by 
breastfeeding status, adjusted for maternal or household smoking 
exposure 
Multiplicative change in urinary cotinine concentration (ng/mL) 









(95% CI), p-value 
Multiplicative Change 
(95% CI), p-value 
Multiplicative Change 
(95% CI), p-value 
Partial vs. 
Exclusive 
1.29 (1.07-1.55), 0.01 1.07 (0.90-1.28), 0.44 1.15 (0.96-1.38), 0.12 
None vs. 
Exclusive 
1.14 (0.96-1.35), 0.14 1.05 (0.89-1.24), 0.55 1.10 (0.93-1.29), 0.28 
Multiplicative change in urinary trans-3’-hydroxycotinine concentration (ng/mL) 









(95% CI), p-value 
Multiplicative Change 
(95% CI), p-value 
Multiplicative Change 
(95% CI), p-value 
Partial vs. 
Exclusive 
1.26 (1.04-1.53), 0.02 1.03 (0.85-1.23), 0.77 1.09 (0.91-1.31), 0.34 
None vs. 
Exclusive 
1.06 (0.88-1.27), 0.53 0.97 (0.82-1.15), 0.71 1.01 (0.85-1.19), 0.93 
Linear regression models were used to model each maternal diet variable against each urinary biomarker. Urinary 
concentrations were log-transformed before fitting regression models. Model coefficients were exponentiated to report 
the multiplicative change in untransformed metabolite concentrations, their 95% confidence intervals, and p-value. P-
values less than or equal to 0.05 are bolded. A multiplicative change of 1.27, for example, corresponds with a 29% 
increase in the urinary metabolite concentration compared to the reference group. In the model that adjusted for 
maternal smoking, those who had a mother report actively smoking during pregnancy (n=22) had 24.9 times (95% CI 
15.373-39.43) higher cotinine concentrations and a 35.74 times (95% CI 22.22-57.48) higher 3HC concentration than 
those who did not. In the model that adjusted for the occurrence of household smoking in early life, those who lived in a 
home where household smoking had occurred had a 4.78 times (95% CI 3.71-6.16) higher cotinine concentrations and 
a 7.42 times (95% CI; 5.73-9.59) higher 3HC concentration than those who had not has smoking occur at the home. 
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Table 3.7. Urinary Cotinine Levels in Infants by Household Tobacco Smoke 
Exposure and Breastfeeding Status 











Exposure (n=163, 11%) 
0.40 (0.26-0.64) 0.56 (0.26-1.20) 0.52 (0.28-1.20) 0.67 
No Household Exposure 
(n=1269, 89%) 
0.09 (0.09-0.10) 0.09 (0.08-0.10) 0.12 (0.09-0.15) 0.21 
Mother is non-smoker 
(n=1410, 98%) 
0.10 (0.09-0.11) 0.10 (0.09-0.12) 0.13 (0.10-0.17) 0.19 
Household Smoke 
Exposure (n=143, 10%) 
0.27 (0.19-0.39) 0.33 (0.17-0.64) 0.30 (0.15-0.62) 0.86 
No Household Exposure 
(n=1267, 90%) 
0.09 (0.09-0.10) 0.09 (0.08-0.10) 0.11 (0.09-0.14) 0.32 






2.11 (1.20-3.70) <0.001 
Geometric mean concentrations of cotinine are reported based on whether the subject was classified as having a 
smoker living at the home, a mother who smoked during pregnancy, and whether and how exclusively they were 
breastfed in the first few months of life. ANOVA tests compared whether the mean log-transformed urinary cotinine 
concentrations differed significantly based on breastfeeding status for each of the conditions held on the left-hand 
column. When these ANOVA tests were repeated for 3HC concentrations, the only significant p-value was seen when 
the mother was an active smoker (p<0.001) (data not shown). 
Breastfeeding 
The presence of a smoker at the home resulted in the greatest average increase in 
urinary cotinine concentrations amongst those partially breastfed (+6.30 ng/mL), 
followed by never breastfed (+4.47 ng/mL) then those exclusively breastfed (+4.28 
ng/mL) when compared to those who did not have a smoker at the home. Those who 
never had breastfed their child had the highest proportion of reported household 
smokers (19.7%), when compared to those who partially (11.7%) or exclusively 
breastfed their child in early life (9.7%). Those who were not breastfed in early life had 
significantly higher concentration of cotinine. However, once adjusted for even a single 
predictor relating to second-hand smoke exposure, breastfeeding difference was no 
longer statistically significant (Table 3.6). Breastfeeding appears to increase an infant’s 




Figure 3.1. Box plots of urinary cotinine concentrations by breastfeeding status 
and maternal smoking status.  
Boxplots show the median and interquartile range, while whisker lines reach to the minimum and 
maximum log-transformed cotinine concentration for each categorization of maternal smoking in 




Figure 3.2. Violin plots of urinary cotinine concentrations by breastfeeding 
status and presence of a household smoker.  
Violin curves overlay boxplots to describe in more detail the distribution of log-transformed 
cotinine concentration. Boxplots show the median and interquartile range, while whisker lines 
reach to the minimum and maximum values of log-transformed cotinine concentration for each 
categorization of maternal smoking in pregnancy by breastfeeding status. 
Infant and Maternal Diet 
When included in multivariable linear regression models, this composite measure of a 
prudent diet was significantly associated with urinary concentrations of cotinine (β= -
0.12, p= 0.04), but not 3HC (β= 0.03, p= 0.64). A likelihood ratio test (LRT) found that 
the addition of the composite prudent diet score variable did slightly improve the fit of the 
cotinine model, with the R2 increasing from 29.9% to 30.1% (p= 0.04). The addition of 
this variable to the 3HC model did not improve its performance and did not increase the 
R2 (from 38.8% to 40.3% (p= 0.64). It may have only slightly improved the cotinine 
prediction model because it had fewer predictors than the 3HC model. Bivariate analysis 
of a prudent/healthy maternal diet found a negative relationship with the infant’s urinary 
cotinine (β= -0.22, p= 0.001) and 3HC concentrations (β= -0.18, p= 0.01). 
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When the more-specific measure of average daily vegetable intake during 
pregnancy was added to multivariable prediction models did not help predict cotinine (β= 
0.01, p= 0.66) or 3HC concentrations (β= 0.02, p= 0.53).  A likelihood ratio test (LRT) 
found that the addition of the average daily vegetable intake variable did not improve the 
fit of the cotinine model, with the R2 unchanged. The addition of this variable to the 3HC 
model did not improve the fit. Maternal vegetable intake was not associated with urinary 
biomarker concentrations on its own and did not change when used in the subset of 
subjects who were exclusively breastfed and lacked a household smoker (n=804) were 
examined. In infants exclusively breastfed, incorporating the average daily vegetable 
intake score variable did not improve the fit of the cotinine model (LRT p=0.69). Similar 
results occurred when adding the prudent/healthy diet score to models in a subset of 
those who were exclusively breastfed (n=890).  
More specific consideration of dietary sources of nicotine using a combination of 
food frequency data, Health Canada portion guidelines, and existing literature of the 
nicotine content in particular foods (see Appendix B) found a small association between 
maternal dietary nicotine intake and their infant’s urinary concentrations of cotinine 
(Multiplicative change of 0.99, p=0.04) but not 3HC (Multiplicative change of 0.99, 
p=0.15). In a subset of those with a low urinary concentration of cotinine (<0.25ng/mL), 
exclusively breastfed with no maternal smoking or household smoking exposure 
(n=555), the association reversed to slightly positive but without statistical significance 




Table 3.8. Multiplicative change in urinary cotinine and trans-3’-
hydroxycotinine concentration by maternal diet 
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Linear regression models were used to model each maternal diet variable against each urinary biomarker. Urinary 
concentrations were log-transformed before fitting regression models. Model coefficients were exponentiated to report 
the multiplicative change in untransformed metabolite concentrations, their 95% confidence intervals, and p-value. P-





Figure 3.3. Scatterplots of maternal prudent/healthy diet scores and infant’s 





Findings from this study allow us to make interpretations about general smoking 
prevalence and behaviours, the risk of childhood asthmatic disease as a result of 
tobacco smoke exposure, and whether a breastfeeding mother's dietary sources of 
nicotine are relevant to the exposure of their breastfed children to nicotine. It appears 
that roughly one-fifth of the infants in our sample could be categorized as having some 
light SHS exposure in their early life. Higher cotinine and 3HC concentrations are 
associated with a slight increase in the risk of recurrent wheeze in childhood, but not 
allergy or asthma. Breastfeeding only increased an infant’s urinary metabolite 
concentrations when the mother had been or was a smoker, and a maternal diet high in 
healthy vegetables, or vegetables containing nicotine was not related to concentrations 
detected in breastfed infants with no household or maternal smoking exposure. 
Smoking behaviours  
Overall, the findings of this cohort offer encouraging insight into the smoking behaviours 
of mothers and families. A pregnancy cohort from Quebec, Canada found that 13-25% of 
pregnant women will continued to smoke during pregnancy in a sample collected 
between 1998 and 2009 (Bérard, Zhao, & Sheehy, 2016), but only 2-3% of our sample 
smoked throughout their pregnancy. Interestingly, 3% reported smoking going into 
pregnancy and not quitting during the pregnancy, but only 2% reported actively smoking 
during the prenatal questionnaire. Overall smoking rates during pregnancy have been 
dropping over time, with a 2006 estimated national average of 10.5%, and notable 
provincial variation and highest smoking rates found in the Northern Territories (Al-
Sahab, Saqib, Hauser, & Tamim, 2010). A 2010 population-based US study found that 
approximately 25% of women smoke before pregnancy, 12% during pregnancy, and 
17% after delivery (Tong et al., 2013). By comparison, 23.7% of mothers in our study 
smoked at some point before their pregnancy, 18.7% had already quit prior to their 
pregnancy, 5% smoked at the start of their pregnancy, and only 3% never quit 
throughout their pregnancy. 
Of those who did report smoking to occur at the home by inhabitants or visitors, the 
majority of smoking occurred outside (Table 3.2). This may be with intent to minimize 
exposure to the child and mother. Although most household smoking occurred outdoors, 
22-23% of the infants in our sample could be categorized as having some level of 
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second-hand tobacco smoke exposure. More work can be done to increase awareness 
of SHS, particularly amongst those who rent or are in multi-family housing and are more 
vulnerable to exposure resulting from those smoking outside of their household. 
While the majority of those in our study who were not actively smoking during 
pregnancy did not have a smoker living at the home in early life, those who did have a 
smoker at the home had higher concentrations of nicotine metabolites detected in their 
infant. Increasing public awareness that even “unseen” light second-hand and thirdhand 
smoke is detectable in infants and may impart some risk to the infant can help in 
furthering tobacco control and smoking cessation initiatives. 
Asthma risk 
Cotinine and 3HC alone in unadjusted logistic regression models were not strong 
predictors of childhood allergic and asthmatic disease, as would be expected for a 
biomarker of tobacco smoke exposure. Our findings suggest an increased odds of 
recurrent wheeze at 1 and 5 years of age, and reduced risk of atopy at 1 year of age 
with increased urinary concentrations. However, the lack of consistent findings at 3 years 
of age and a low number of cases are reason to be cautious in the interpretation of these 
results. Others have found urinary cotinine to predict the risk of recurrent wheezing but 
not asthma in early childhood, but that the directionality of effect estimates were unstable 
over time (Carlsten et al., 2012). The findings with reduced atopy risk adds to the 
inconsistencies seen in existing literature around passive smoking exposure and allergic 
sensitization (Ciaccio & Gentile, 2013; Thacher et al., 2016), and may be implicated by 
the immunosuppressive or dysregulating properties of nicotine (Piao et al., 2009). Odds 
ratios from the use of questionnaire responses to predict risk followed similar trends, with 
some significant increase in the risk of recurrent wheeze at 1 year of age, and some 
protection of atopy at 3 years of age. 
Low and/or intermittent tobacco smoke exposure is not a clinically significant risk 
factor for asthmatic disease in childhood in our sample. Inconsistencies in effect sizes 
may be due a lack of power from a low number of cases. It is reasonable that we are not 
seeing a relationship between detected concentrations and clinical diagnosis because of 
implications with dietary routes of exposure. If the source of the nicotine exposure for 
these infants is predominantly or exclusively through vegetables, a source of anti-
inflammatory and antioxidant agents, then; 
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A) The inflammatory properties of nicotine (and other chemical toxicants 
released by harmful tobacco smoke) may be counteracted by 
antioxidant nutrients and other protective properties of breastfeeding 
and/or a diet high in anti-inflammatory and antioxidant fruits and 
vegetables. This oxidative-stress relationship in childhood asthma and 
allergic disease risk has been described by others (Sordillo et al., 
2019). Micronutrients delivered from a diet high in fruits, vegetables 
and antioxidant-containing foods can increase resiliency against 
oxidative stresses such as tobacco smoke (Wilson, Finkelstein, 
Blumkin, Best, & Klein, 2011). 
B) If the nicotine is delivered to the infant through breast milk from 
mothers who eat vegetables known to contain small amounts of 
nicotine instead of being delivered by tobacco smoke, the metabolites 
of this nicotine cease to reflect risks associated with tobacco smoke 
and instead reflect the properties of a vegetable-rich diet (Hosseini, 
Berthon, Wark, & Wood, 2017).  As a result, the concentrations may 
indicate protective exposures associated with a reduced asthma and 
allergy risk rather than an increased risk associated with tobacco 
smoke exposure. 
Breastfeeding  
Results corroborate that breast milk is an additional route of nicotine exposure for 
breastfed infants (Becker et al., 1999). One study found infant urinary cotinine levels to 
be 5 times higher in children of smoking mothers who were breastfed compared to 
children with smoking mothers who were not breastfed (Becker et al., 1999). When the 
mother is a non-smoker or there is no reported household smoker, there is a negligible 
difference in infant’s urinary cotinine concentration based on breastfeeding status. When 
the mother is a smoker, there is a significant difference in the infant’s urinary cotinine 
concentration based on breastfeeding status. Smokers who breastfeed should be 
encouraged to reduce or quit smoking and increase their intake of antioxidants rather 
than reduce or quit breastfeeding and maintain their smoking behaviour. 
Our study also identified that those who breastfeed more also report less 
household smoking exposure. Of those who exclusively breastfeed, those who report 
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some household smoke exposure in early life have infants with a higher urinary cotinine 
and 3HC concentration than those without household exposure. Even with most 
household smoking reportedly occurring outdoors, the report of a smoker living at the 
home impacts how much tobacco smoke the infant is exposed to. This exposure likely 
occurs through light second-hand smoke, such as the infiltration of outdoor smoking 
through a window, or third-hand smoke from clothing and other fabrics that act as 
reservoirs from earlier smoke exposure. 
Infant and maternal diet  
The majority of the sample were exclusively breastfeeding at 3 months of age (62%), 
followed by those combining breastfeeding with formula (24%), and those strictly formula 
feeding (11%). Dietary sources of nicotine may be relevant when exploring exposure 
sources for a population with a notably low prevalence of tobacco smoking. A high-
vegetable diet, which likely carries some detectable nicotine exposure, did not increase 
the urinary concentrations of any infants regardless of breastfeeding status. Daily 
average vegetable intake, and the healthy diet variable both were negatively associated 
with infants' urinary concentrations of cotinine and trans-3’-hydroxycotinine. This finding 
is likely because these variables act as a proxy for other protective lifestyle factors. For 
example, those who had mothers that ate a healthier diet with more vegetables had a 
partner with higher education, and a higher household income, and less tobacco smoke 
exposure. Altogether, a higher vegetable diet may be indicative of higher socioeconomic 
status, a factor inherently linked to the use of cigarettes (Cui, Shooshtari, Forget, Clara, 
& Cheung, 2014). We found no association between maternal dietary nicotine intake and 
their infant’s urinary concentrations of cotinine and 3HC, even when restricting analysis 
to a group of infants where dietary nicotine sources becomes most possible. However, it 
remains reasonable that cotinine derived from a vegetable-rich diet may be protective of 
childhood asthma and wheeze, warranting more focused data collection and analysis 




3.6. Limitations and Future Directions 
There are important limitations to this study. While the low prevalence of tobacco smoke 
exposure in this cohort should be celebrated, this cohort does slightly underestimate true 
exposure experienced by the Canadian population. The CHILD cohort is known to 
contain subjects with parents who are more affluent, educated, and allergic or 
predisposed to sensitivity than the general Canadian population. Mothers who smoke 
during pregnancy generally are of low socioeconomic status, non-immigrant, single, 
have a chronic disease and are not in attendance of prenatal classes nor linked to a 
family doctor (Al-Sahab et al., 2010; Cui et al., 2014). We acknowledge that this study 
population of urbanized, relatively affluent people is not reflective of the entire Canadian 
population, and that the findings of this study are not generalizable to all provinces. 
There were higher proportions of subjects from the Manitoba-based and Vancouver sites 
that were available for this analysis when compared to the overall CHILD cohort which 
may impact results. There are also regional differences in smoking rates, with the 
Northern territories having the highest provincial rates of smoking during pregnancy (Al-
Sahab et al., 2010). Specifically, those of lower income, rural homestead and those 
belonging to a visible minority where smoking prevalence is hypothesized to be higher 
are underrepresented and may therefore underrepresent the proportion of smoking 
exposure to expectant and new mothers in the Canadian population. Cotinine may still 
be a useful validation measure of smoking exposure in these populations of the 
Canadian public, as well as other jurisdictions where smoking prevalence is higher. 
At the time of data collection for questionnaires used by this study, e-cigarette 
use was not yet popularized and marijuana use was still illegal in Canada. We recognize 
that we have been unable to assess for novel, non-cigarette tools for tobacco exposure, 
and encourage that future analysis make use of data on marijuana and e-cigarette use 
when characterizing tobacco smoke exposure. 
Finally, the dietary data used for this project were not ideal for addressing our 
specific question of dietary sources of nicotine. The food frequency questionnaire did not 
separate nightshade-family vegetables (high in nicotine) from other vegetables (low in, or 
void of nicotine). Thus, our analysis was limited to variables representing exposure to all 
vegetables, of which an unknown portion are expected to be from the nightshade family. 
The amount is expected to vary by region, season, and cultural differences in food 
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preference. The potential for nightshade vegetables to contribute dietary nicotine to 
children needs further evaluations with modern levels of detection to better understand 
cotinine and 3HC concentrations as indicators of risk.  As well, the food frequency 
questionnaire was completed during pregnancy so we are unable to determine how 
maternal diets change over time, and how this may impact their children. Future work 
should examine multiple exposure routes including food sources and dermal exposure to 
nicotine to enable better interpretation of lower concentrations of nicotine metabolites 
and any effect they may have on the risk of asthma or other inflammatory diseases in 
their children.  
3.7. Conclusions 
The majority of our sample had urinary concentrations indicative of very light second-
hand smoke and thirdhand smoke exposure, and this exposure was reported not to 
occur as a result of the mother. Increasing cotinine and trans-3’-hydroxycotinine 
concentrations in infant’s were associated with a slightly increased odds of having 
recurrent wheeze at 1 and 5 years of age, and a reduced odds of atopy at 1 year of age. 
These relationships were not as strong in a subsample of those exclusively breastfed, 
which may indicate that breast milk inhibits or counters the inflammatory effect of 
nicotine. Breastfeeding is an important route of nicotine exposure for second-hand and 
thirdhand smoke exposure and can increase an infant’s exposure when the mother is a 
smoker. Breastfeeding does not appear to increase a child’s exposure to nicotine when 
in a household where other smoking occurs, perhaps because the majority of household 
smoking occurs outdoors. Our findings do not suggest that a maternal diet high in 
vegetables or nicotine-containing vegetables can result in an increased intake of nicotine 
to the child, even when considering exclusively breastfed infants where dietary sources 
are most relevant. However, this analysis is limited to the use of data that does not offer 
the level of specificity needed to determine how a vegetable-rich diet influences 
exposure and any risk as a result of dietary nicotine versus tobacco-smoke derived 
nicotine. More specific analysis is needed to confirm these findings, using food-specific 
micronutrient and nicotine testing and tracking of nicotine concentrations from food 
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Chapter 4.  
 
Conclusions 
4.1. Overall Contributions 
This thesis has been able to address the 3 overall objectives of the project. It implements 
quantitative analysis on questionnaires, biomarker and clinical assessment data from the 
CHILD cohort study, and regression modelling approaches that combine traditional and 
machine learning conventions for variable selection. 
What are the levels and key sources of nicotine metabolites in a population of 
Canadian infants? 
The geometric mean cotinine concentration of the infants was 0.12ng/mL (95% CI: 0.11-
0.13ng/mL), while the geometric mean 3HC concentration was 0.22 ng/mL (95%CI: 
0.21-0.24ng/mL). While 76% and 89% of the sample had detectable concentrations of 
cotinine and 3HC, the majority (77%) of infants have concentrations indicative of light 
SHS, THS, or none at all. Second-hand smoke exposure during pregnancy, the amount 
of smoking that occurs at the home during pregnancy and after the child’s birth, and the 
smoking status of the mother were key predictors of variation in urinary metabolite 
concentrations of infants at 3-4 months of age. Factors relating to socioeconomic status, 
housing, breastfeeding, and third-hand smoke exposure were also important to 
explaining concentrations detected in the infants. 
Does diet contribute to low but detectable levels of cotinine in children?  
Breastfeeding was an important predictor of nicotine metabolite concentrations in infants, 
because it serves as an additional route of exposure to nicotine. While it is possible that 
some of the nicotine passed from mother to child through breastmilk could come from 
dietary sources (ie. Nightshade vegetables), our findings indicate that breastfeeding only 
made a difference to an infant’s measurable exposure in settings where the mother had 
reported smoked. A maternal diet high in vegetables was not associated with a child’s 




What are the clinical implications and relevance of these concentrations? 
There was no significant relationship between concentrations detected in these infants 
and asthma diagnosis in childhood. However, there is a relationship with recurrent 
wheeze at 1 and 5 years of age, but not at 3 years. This inconsistency over time 
warrants caution and more research is needed on subclinical manifestations of 
inflammation that may be linked to light SHS, THS exposure, and dietary nicotine 
consumption. 
4.2. Discussion  
While our findings indicate that maternal smoking rates are very low, pregnant women 
and new mothers may still be exposed to smoking by others at their home. Pregnant 
women, mothers and households expecting a child smoke less than the national 
average, with those who are younger, less educated, and of lower socioeconomic status 
smoking the most (Cui, Shooshtari, Forget, Clara, & Cheung, 2014). About half of all 
women that smoke daily before their pregnancy will continue to smoke during their 
pregnancy, though the majority of this will be ‘light’ smoking (Lange, Probst, Rehm, & 
Popova, 2018), which is defined as 10-14 or fewer cigarettes per day (Cui et al., 2014; 
Lange et al., 2018). This definition is problematic, as it labels a considerable 
consumption of cigarettes in a way that can be perceived as carrying very little risk. 
Family dynamics, housing, and physiological changes in metabolism are all important 
factors when encouraging pregnant women or those who may become pregnant to quit 
smoking, as well as other members of their household. Globally, Canada has some of 
the highest proportions of smoking during pregnancy, though this is driven primarily by 
the higher smoking rates during pregnancy seen in the Northern Territories (Al-Sahab, 
Saqib, Hauser, & Tamim, 2010; Lange et al., 2018). To facilitate the success of smoking 
cessation, having other household members on-board with quitting by engaging in 
smoking cessation or consciously reducing their smoking is key. One study exploring the 
paternal narrative of smoking cessation found that those who were aware of the dangers 
of passive smoke were more likely to quit, and that parenthood did inspire fathers to 
modify their smoking behaviours (Bottorff, Radsma, Kelly, & Oliffe, 2009). For knowledge 
translation efforts to be effective, more research is needed on the health impacts of low 
but detectable levels of smoke exposure, as well as the reach and persistence of third-
hand smoke in the home. Only in the past few years have researchers begun to tease 
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out the health effects and pervasiveness of third-hand smoke (Hang et al., 2017; Leung, 
Ho, Wang, & Lam, 2018; Northrup, Jacob, et al., 2016; Northrup, Matt, Hovell, Khan, & 
Stotts, 2016). As a relatively new phenomena in public health, the public at large lacks 
awareness and understanding of third-hand smoke, making THS an indispensable 
component of tobacco control (Díez-Izquierdo et al., 2018).  
Our findings indicate that increased exposure to tobacco smoke, albeit light, may 
be associated with an increased risk of recurrent wheeze. While not enough for a clinical 
diagnosis of asthma, recurrent wheezing in early life is a concern for the future 
development of asthma and an increased likelihood of other comorbidities such as 
allergy. 
Exploration of the data found that breastfeeding is an additional route of nicotine 
exposure for infants, but that any difference in nicotine consumption as a result of 
breastfeeding is only significant when the in context of having a mother who smokes or 
smoked during pregnancy. Infants who were breastfed more had lower concentrations of 
cotinine and 3HC, and less reported exposure to SHS. The majority of the infants in our 
study were exclusively being breastfed and may be more influenced by the mother’s diet 
than those who weren’t. While we couldn’t confirm whether a diet rich in nicotine-
containing vegetables contributed small but detectable concentrations of nicotine to a 
breastfed child with the data available, this concept should not be dismissed. Any 
nicotine sourced from a vegetable-rich diet would be a marker of a diet high in anti-
inflammatory and antioxidizing properties, which could abate any risk of inflammatory 
disease associated with light exposure to second-hand and third-hand smoke (Litonjua 
et al., 2006; Martindale et al., 2005; Sordillo et al., 2019). The potential for oxidative 
balancing in early life is of particular importance in populations with little smoking 
exposure and relatively high prevalence of breastfeeding (Hovell, Zakarian, Wahlgren, 
Matt, & Emmons, 2000a; Sordillo et al., 2019).  
4.3. General Conclusions and Future Outlook 
In the context of reduced tobacco smoking in urbanized centers, particularly in affluent 
populations, the use of biomarkers to accurately depict an infant’s true exposure to 
second-hand and third-hand smoke has become problematic. Researchers need to 
combine qualitative and quantitative data on smoking behaviours to better educate the 
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public and prevent exposure to second-hand and third-hand smoke in infants and young 
children. We have added to a growing body of research stating that a combination of 
biomarkers and questionnaires should be used to assess tobacco smoke exposure, with 
particular emphasis on household characteristics that may affect the persistence of 
tobacco smoke in indoor air (Hovell, Zakarian, Wahlgren, Matt, & Emmons, 2000b; 
Kalkbrenner et al., 2010).  
Pregnancy presents an opportune time to promote smoking cessation or 
reduction, not only for the mothers but also for others in the home who may smoke. This 
project encourages a need to improve our ability to accurately measure tobacco smoke 
exposure in populations with light exposure, and to recognize the possible implications 
of non-smoking sources of nicotine. The sub-clinical implications of low but persistent 
nicotine exposure through THS or intermittent SHS require further investigation. The 
results from this thesis can inform decision-makers and provide recommendation of how 
biomarkers and questionnaires should be used as tools to assess exposure to tobacco 
smoke, and how the implication of THS should be further researched to better inform 
knowledge translation and tobacco control measures. The challenges of public policy will 
be more complicated when addressing environmental tobacco smoke exposure. In 
addition to physicians, parents, and teachers, stakeholders in real estate, bylaw 
enforcement, public and private transportation operators must be considered in order to 
make control of low-level smoke exposure as ubiquitous as the smoke itself (Burton, 
2011; Jacob et al., 2017; Matt et al., 2011; Northrup, Jacob, et al., 2016). While the 
Canadian population overall is reducing the rates of smoking, particularly during 
pregnancy and when around children – both as a result of policy and social pressures, 
our understanding of cotinine as a measure of smoking and subsequent clinical risk 





Al-Sahab, B., Saqib, M., Hauser, G., & Tamim, H. (2010). Prevalence of smoking during 
pregnancy and associated risk factors among Canadian women: a national 
survey. BMC Pregnancy and Childbirth, 10(1), 24. https://doi.org/10.1186/1471-
2393-10-24 
Burton, A. (2011). Does the smoke ever really clear? Thirdhand smoke exposure raises 
new concerns. Environmental Health Perspectives, 119(2), A70-4. 
https://doi.org/10.1289/ehp.119-a70 
Cui, Y., Shooshtari, S., Forget, E. L., Clara, I., & Cheung, K. F. (2014). Smoking during 
Pregnancy: Findings from the 2009–2010 Canadian Community Health Survey. 
PLoS ONE, 9(1), e84640. https://doi.org/10.1371/journal.pone.0084640 
Díez-Izquierdo, A., Cassanello-Peñarroya, P., Lidón-Moyano, C., Matilla-Santander, N., 
Balaguer, A., & Martínez-Sánchez, J. M. (2018). Update on thirdhand smoke: A 
comprehensive systematic review. Environmental Research, Vol. 167. 
https://doi.org/10.1016/j.envres.2018.07.020 
Hang, B., Wang, P., Zhao, Y., Sarker, A., Chenna, A., Xia, Y., … Mao, J. H. (2017). 
Adverse health effects of thirdhand smoke: From cell to animal models. 
International Journal of Molecular Sciences, Vol. 18. 
https://doi.org/10.3390/ijms18050932 
Hovell, M. F., Zakarian, J. M., Wahlgren, D. R., Matt, G. E., & Emmons, K. M. (2000a). 
Reported measures of environmental tobacco smoke exposure: Trials and 
tribulations. Tobacco Control, 9(SUPPL. 3). 
https://doi.org/10.1136/tc.9.suppl_3.iii22 
Hovell, M. F., Zakarian, J. M., Wahlgren, D. R., Matt, G. E., & Emmons, K. M. (2000b). 
Reported measures of environmental tobacco smoke exposure: Trials and 
tribulations. Tobacco Control, 9(SUPPL. 3). 
https://doi.org/10.1136/tc.9.suppl_3.iii22 
Jacob, P., Benowitz, N. L., Destaillats, H., Gundel, L., Hang, B., Martins-Green, M., … 
Whitehead, T. P. (2017). Thirdhand Smoke: New Evidence, Challenges, and 
Future Directions. Chemical Research in Toxicology, 30(1), 270–294. 
https://doi.org/10.1021/acs.chemrestox.6b00343 
Kalkbrenner, A. E., Hornung, R. W., Bernert, J. T., Hammond, S. K., Braun, J. M., & 
Lanphear, B. P. (2010). Determinants of serum cotinine and hair cotinine as 
biomarkers of childhood secondhand smoke exposure. Journal of Exposure 




Lange, S., Probst, C., Rehm, J., & Popova, S. (2018). National, regional, and global 
prevalence of smoking during pregnancy in the general population: a systematic 
review and meta-analysis. The Lancet, 6, 769–776. 
https://doi.org/10.1016/S2214-109X(18)30223-7 
Leung, L. T., Ho, S. Y., Wang, M. P., & Lam, T. H. (2018). Secondhand smoke from 
multiple sources, thirdhand smoke and respiratory symptoms in Hong Kong 
adolescents. Nicotine and Tobacco Research, 20(2). 
https://doi.org/10.1093/ntr/ntw302 
Litonjua, A. A., Rifas-Shiman, S. L., Ly, N. P., Tantisira, K. G., Rich-Edwards, J. W., 
Camargo, C. A., … Gold, D. R. (2006). Maternal antioxidant intake in pregnancy 
and wheezing illnesses in children at 2 y of age. The American Journal of Clinical 
Nutrition, 84(4), 903–911. https://doi.org/10.1093/ajcn/84.4.903 
Martindale, S., McNeill, G., Devereux, G., Campbell, D., Russell, G., & Seaton, A. 
(2005). Antioxidant Intake in Pregnancy in Relation to Wheeze and Eczema in 
the First Two Years of Life. American Journal of Respiratory and Critical Care 
Medicine, 171(2), 121–128. https://doi.org/10.1164/rccm.200402-220OC 
Matt, G. E., Quintana, P. J. E., Destaillats, H., Gundel, L. A., Sleiman, M., Singer, B. C., 
… Hovell, M. F. (2011). Thirdhand Tobacco Smoke: Emerging Evidence and 
Arguments for a Multidisciplinary Research Agenda. Environmental Health 
Perspectives, 119(9), 1218–1226. https://doi.org/10.1289/ehp.1103500 
Northrup, T. F., Jacob, P., Benowitz, N. L., Hoh, E., Quintana, P. J. E., Hovell, M. F., … 
Stotts, A. L. (2016). Thirdhand Smoke: State of the Science and a Call for Policy 
Expansion. Public Health Reports, 131(2). 
https://doi.org/10.1177/003335491613100206 
Northrup, T. F., Matt, G. E., Hovell, M. F., Khan, A. M., & Stotts, A. L. (2016). Thirdhand 
smoke in the homes of medically fragile children: Assessing the impact of indoor 
smoking levels and smoking bans. Nicotine and Tobacco Research, 18(5). 
https://doi.org/10.1093/ntr/ntv174 
Sordillo, J. E., Rifas-Shiman, S. L., Switkowski, K., Coull, B., Gibson, H., Rice, M., … 
Oken, E. (2019). Prenatal oxidative balance and risk of asthma and allergic 





Appendix A.  
 
Supplemental Information for Chapter 2:  
Assessing tobacco smoke exposure in Canadian 
infants using questionnaires, biomarkers, and 
machine learning 
Appendix A figures and tables 
Figure A.1. Sample Selection Flow Chart .................................................................. 89 
Table A.1a. Distribution of Metabolite Concentrations by Smoking Exposure ............ 90 
Table A.1b. Distribution of Metabolite Concentrations by Household Characteristics 94 
Table A.1c. Distribution of Metabolite Concentrations by Socioeconomic factors, 
parental disease history and ethnicity, and infant diet. ............................ 96 
Figure A.2a. Variable importance plot for cotinine concentration .............................. 100 
Figure A.2b. Variable importance plot for trans-3’-hydroxycotinine concentration ..... 101 
Table A.2. Variable Importance and R2 Scores for Potential Predictors ................. 102 
Figure A.3a. Distribution of log-transformed Cotinine concentration following imputation 
of concentrations below detection ......................................................... 106 
Figure A.3b. Distribution of log-transformed Hydroxycotinine concentration following 
imputation of concentrations below detection ....................................... 107 
Table A.3. Predictor data dictionary ........................................................................ 108 
Table A4.  Cotinine Multivariable Linear Regression Model and Multiplicative Change 
in log-transformed Cotinine concentrations ........................................... 111 
Table A5.  Trans-3’-Hydroxycotinine Multivariable Linear Regression Model and 
Multiplicative Change in log-transformed trans-3’-Hydroxycotinine 






Figure A.1. Sample Selection Flow Chart 
Of the 3,455 children in the CHILD Study, 2,607 had urine samples collected at the 3-4 month 
home visit. 2,607 urine samples are available, with 2,509 of these samples remaining after 
excluding those with inconclusive results errors. These results errors include results that were 
duplicates, experienced interference with the sample, had insufficient volume for testing, or with a 
specific gravity measures above a 3 standard deviation cutoff. Of the 2,509 participants with 
metabolite data, 589 (23.5%) had a cotinine concentration below the LOD, and 271 (10.8%) had 
a 3HC concentration below the LOD. A subset of these 2,509 who have complete data, including 
those who could not have a result reported because the concentration was below the level of 
detection (0.03ng/mL) were selected as the current sample size. This sample was then restricted 
to those who also had complete information for all demographic and potential predictors of 
tobacco smoke exposure, limiting the sample size to 2,017. 
  
Children in the 
CHILD Cohort 
n=3,455
Participants without adequate 












Participants without complete 
predictor or demographic data
n=492
Participants without urine 




Table A.1a. Distribution of Metabolite Concentrations by Smoking Exposure 
Predictor Variable % (N) Geometric mean 






Prenatal maternal smoking p<0.001 p<0.001 
Never Smoked 91.9% (n=1853) 0.10 (0.09-0.10) 0.18 (0.17-0.19) 
Quit during pregnancy 4.4% (n=88) 0.82 (0.52-1.29) 2.30 (1.34-3.93) 
Did not quit smoking 3.9% (n=76) 1.15 (0.62-2.16) 3.24 (1.68-6.26) 
Maternal smoking status in pregnancy p<0.001 p<0.001 
Never Smoked 97.5% (n=1967) 0.10 (0.10-0.11) 0.20 (0.19-0.21) 
Daily or Occasional 
Smoker 
2.6% (n=50) 7.13 (4.18-12.14) 21.96 (12.21-39.48) 
Pre-prenatal maternal smoking p<0.001 p<0.001 
Never Smoked 76.1% (n=1535) 0.09 (0.09-0.10) 0.17 (0.16-0.18) 
Quit prior to pregnancy 17.7% (n=358) 0.12 (0.10-0.15) 0.27 (0.23-0.31) 
Did not quit prior to 
pregnancy 
6.1% (n=124) 1.81 (1.19-2.77) 5.16 (3.19-8.34) 
Was the mother exposed to a smoker 
at the home during pregnancy p<0.001 p<0.001 
Yes, Regularly 1.2% (n=25) 2.04 (0.97-4.32) 6.26 (2.87-13.69) 
Yes, Occasionally 1.7% (n=35) 0.85 (0.44-1.62) 2.39 (1.16-4.92) 
No 97.0% (n=1957) 0.11 (0.10-0.12) 0.21 (0.19-0.22) 
Household smoking during pregnancy p<0.0001 p<0.0001 
No  88.9% (n=1794) 0.10 (0.09-0.10) 0.18 (0.17-0.19) 
Yes 11.1% (n=223) 0.56 (0.44-0.71) 1.44 (1.11-1.87) 
Where household smoking occurs 
during pregnancy p<0.0001 p<0.0001 
Inside 1.0% (n=20) 3.00 (1.46-6.15) 8.58 (3.68-19.99) 
Near Open Window or 
in Garage 
1.9% (n=38) 0.91 (0.54-1.55) 2.62 (1.39-4.94) 
Outside 8.8% (n=178) 0.47 (0.36-0.61) 1.19 (0.89-1.59) 
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Predictor Variable % (N) Geometric mean 






Mother reports exposure during 
pregnancy p<0.0001 p<0.0001 
Recent Exposure 21.1% (n=425) 0.29 (0.24-0.35) 0.66 (0.54-0.81) 
No recent exposures 78.9% (n=1592) 0.09 (0.08-0.10) 0.29 (0.24-0.35) 
Mother reports average daily exposure 
to smoke during pregnancy 
(continuous) 
p <0.0001 p<0.0001 
None 79.0% (n=1593) 0.09 (0.08-0.10) 0.17 (0.16-0.26) 
0.25 hr/day 14.8% (n=299) 0.21 (0.18-0.26) 0.46 (0.38-0.57) 
0.5-1 hr/day 3.6% (n=72) 0.49 (0.27-0.89) 1.10 (0.57-2.13) 
2-4hrs/day 1.4% (n=29) 0.45 (0.19-1.07) 1.18 (0.46-3.02) 
5-24hrs/day 1.2% (n=24)) 1.91 (0.72-5.09) 6.05 (2.16-16.92) 
Mothers days exposure to smoke 
during pregnancy in past 2 weeks 
(continuous) 
p<0.0001 p<0.0001 
None 78.9% (n=1592) 0.09 (0.08-0.10) 0.17 (0.16-0.18) 
1 day 5.0% (n=100) 0.12 (0.09-0.16) 0.26 (0.19-0.35) 
2 days 4.1% (n=83) 0.17 (0.12-0.23) 0.39 (0.28-0.54) 
3-4 days 4.0% (n=80) 0.22 (0.15-0.32) 0.45 (0.30-0.69) 
5-6 days 1.2% (n=24) 0.27 (0.14-0.51) 0.50 (0.27-0.94) 
7-8 day 1.3% (n=27) 0.26 (0.15-0.47) 0.45 (0.22-0.94) 
9-12 days 1.3% (n=27) 0.38 (0.18-0.80) 1.08 (0.46-2.55) 
14 days (every day) 4.2% (n=84) 1.84 (1.09-3.10) 5.09 (2.87-9.03) 
Household smoking since birth p<0.0001 p<0.0001 
No  87.8% (n=1771) 0.10 (0.09-0.10) 0.17 (0.16-0.19) 
Yes 12.2% (n=246) 0.50 (0.38-0.65) 1.36 (1.02-1.81) 
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Predictor Variable % (N) Geometric mean 






Where household smoking occurs 
during child’s early life 
Inside v. None 
p<0.001 
Window v. None 
p<0.001 
Outside v. None 
p<0.001 
Inside v. None p<0.001 
Window v. None 
p<0.001 
Outside v. None 
p<0.001 
Inside 0.5% (n=10) 2.07 (0.79-5.44) 6.45 (2.50-16.63) 
Near Open Window or 
in Garage  
1.6% (n=32) 1.30 (0.63-2.71) 4.18 (1.98-8.85) 
Outside 11.2% (n=225) 0.43 (0.33-0.57) 1.16 (0.86-1.57) 
Cigarettes smoked daily at the home 
during child’s early life p<0.0001 p<0.0001 
None 91.0% (n=1836) 0.10 (0.09-0.10) 0.18 (0.17-0.19) 
1-5 cigarettes/day 5.6% (n=113) 0.42 (0.29-0.60) 1.17 (0.78-1.74) 
6-10 cigarettes/day 1.7% (n=35) 1.27 (0.64-2.50) 3.69 (1.74-7.82) 
10+ cigarettes/day 1.6% (n=33) 2.80 (1.29-6.08) 7.93 (3.37-18.63) 
Parent reports smoking exposure to 
child in early life p<0.0001 p<0.0001 
None 92.6% (n=1868) 0.11 (0.10-0.12) 0.20 (0.19-0.22) 
Some 7.4% (n=149) 0.30 (0.22-0.40) 0.80 (0.59-1.09) 
Days baby was exposed to smoke 
during the past week, early life 
(continuous) 
p<0.0001 p<0.0001 
None 95.6% (n=1928) 0.11 (0.10-0.12) 0.21 (0.19-0.22) 
1 day 2.1% (n=43) 0.33 (0.20-0.54) 0.78 (0.47-1.30) 
2 days 0.7% (n=14) 0.26 (0.10-0.71) 0.96 (0.33-2.82) 
3-5 days 0.5% (n=9) 0.19 (0.06-0.62) 0.50 (0.13-2.02) 
6-7 days 1.1% (n=23) 1.30 (0.46-3.64) 4.11 (1.55-10.91) 
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Hours of smoke exposure in the past 
week to child, early life p<0.0001 p<0.0001 
None 95.6% (n=1929) 0.11 (0.10-0.12) 0.21 (0.19-0.22) 
10 hours /week 3.7% (n=74) 0.37 (0.24-0.58) 1.02 (0.64-1.61) 
10 to 20 hours/week 0.2% (n=5) 0.78 (0.10-6.34) 1.60 (0.14-18.76) 
More than 20 
hours/week 
1.0% (n=20) 1.20 (0.29-5.04) 4.01 (1.01-15.85) 
The proportion and crude number of sample subjects that corresponds to each level of household characteristic 
variables is reported to the nearest whole number. The geometric mean (95% Confidence interval) of the corrected and 
log-transformed Cotinine distribution for each level of each variable is also reported to the nearest two decimal places. 




Table A.1b. Distribution of Metabolite Concentrations by Household 
Characteristics 
Characteristic % (N) Geometric mean 
urinary Cotinine 





Dwelling Type p<0.0001 p<0.0001 
Single Family  55.8% (n=1470) 0.10 (0.10-0.11) 0.20 (0.18-0.22) 
Multi-Family or 
Apartment 
25.8% (n=521) 0.15 (0.13-0.18) 0.29 (0.25-0.34) 
Trailer or Other 1.2% (n=26) 0.24 (0.11-0.49) 0.53 (0.23-1.19) 
Carpeted Flooring  CLS v. Not p=0.06 
CMR v. Not p=0.07 
CCR v Not p<0.0001 
CLS v. Not p=0. 19 
CMR v. Not p=0.007 
CCR v. Not p<0.0001 
Carpeted Living Space 
(LS) 
26.7% (n=539) 0.13 (0.11-0.15) 0.24 (0.20-0.27) 
LS Not Carpeted 73.3% (n=1478) 0.11 (0.10-0.12) 0.22 (0.20-0.24) 
Carpeted Mom’s Room 
(MR) 
50.0% (n=1009) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
MR not carpeted 50.0% (n=1008) 0.12 (0.11-0.13) 0.24 (0.22-0.27) 
Carpeted Child’s Room 
(CR) 
39.9% (n=804) 0.10 (0.09-0.12) 0.20 (0.18-0.22) 
CR Not Carpeted 42.5% (n=857) 
*356 no child’s 
room 
0.11 (0.10-0.13) 0.21 (0.19-0.23) 
Air Conditioning (AC) p=0.00001 p<0.00001 
None 55.3% (n=1115) 0.12 (0.11-0.13) 0.21 (0.18-0.23) 
Central AC 49.2% (n=992) 0.10 (0.09-0.11) 0.20 (0.18-0.22) 
Window or Portable Unit 19.9% (n=402) 0.17 (0.14-0.20) 0.38 (0.31-0.46) 
Rent vs. Own Home p<0.0001 p<0.0001 
Rent 34.3% (n=692) 0.19 (0.16-0.22) 0.36 (0.31-0.43) 
Own 90.1% (n=1817) 0.10 (0.09-0.11) 0.19 (0.18-0.21) 
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Bedrooms in Home p=0.09 p=0.007 
No bedrooms <1% (n=2) 0.14 (N/A) 0.99 (N/A) 
1-3 bedrooms 73.2% (n=1476) 0.12 (0.11-0.13) 0.24 (0.22-0.26) 
4-6 bedrooms 26.3% (n=531) 0.10 (0.09-0.12) 0.19 (0.16-0.22) 
7+ bedrooms 0.4% (n=8) 0.08 (0.03-0.22) 0.15 (0.05-0.48) 










Basement (B) 31.6% (n=637) 0.10 (0.09-0.11) 0.20 (0.17-0.22) 
Not in Basement 37.5% (n=756) 0.11 (0.10-0.12) 0.21 (0.19-0.24) 
No Basement 30.9% (n=624) 0.15 (0.13-0.17)  0.27 (0.24-0.31) 
Kitchen (K) 18.2% (n=368) 0.12 (0.10-0.14) 0.21 (0.17-0.25) 
Not in Kitchen 81.8% (n=1649) 0.12 (0.11-0.13) 0.23 (0.21-0.25) 
Living Space (LS) 45.0% (n=907) 0.11 (0.10-0.12) 0.20 (0.18-0.22) 
Not in Living Space 55.0% (n=1110) 0.12 (0.11-0.13) 0.24 (0.22-0.27) 
Mom’s bedroom (MB) 14.0% (n=282) 0.11 (0.10-0.13) 0.24 (0.20-0.29) 
Not in Mom’s bedroom 86.0% (n=1735) 0.12 (0.11-0.13) 0.22 (0.20-0.24) 
Bathroom (B) 35.1% (n=707) 0.11 (0.10-0.12) 0.19 (0.17-0.22) 
Not in Bathroom 64.9% (n=1310) 0.12 (0.11-0.13) 0.24 (0.22-0.27) 
Car Ownership p=0.002 p=0.00002 
No Cars 6.0% (n=122) 0.20 (0.14-0.28) 0.45 (0.31-0.64) 
1 Car 41.4% (n=835) 0.12 (0.10-0.13) 0.21 (0.19-0.24) 
2 Car 46.7% (n=942) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
3+ Cars 5.9% (n=118) 0.11 (0.08-0.15) 0.28 (0.20-0.39) 
The proportion and crude number of sample subjects that corresponds to each level of household characteristic 
variables is reported to the nearest whole number. The geometric mean (95% Confidence interval) of the corrected and 
log-transformed Cotinine distribution for each level of each variable is also reported to the nearest two decimal places. 
P-values represent test for comparing means between levels of each predictor. P-values less than 0.05 are bolded. 
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Household Income p<0.0001 p<0.0001 
$0-49,999/year 10.0% (n=201) 0.26 (0.20-0.34) 0.55 (0.43-0.76) 
$50,000-99,999/year 31.3% (n=631) 0.14 (0.12-0.16) 0.26 (0.22-0.29) 
$100,000-149,999/year 26.4% (n=533) 0.09 (0.08-0.11) 0.19 (0.16-0.21) 
$150,000+/year 23.3% (n=469) 0.08 (0.07-0.09) 0.14 (0.12-0.16) 
Prefers to not say 9.1% (n=183) 0.12 (0.10-0.15) 0.28 (0.22-0.36) 
Paternal Education p<0.0001 p<0.0001 
Highschool or less 12.4% (n=250) 0.26 (0.20-0.33) 0.59 (0.45-0.78) 
Some Post-Secondary 16.7% (n=336) 0.16 (0.13-0.20) 0.35 (0.28-0.43) 
Completed Post-
Secondary 
54.5% (n=1099) 0.10 (0.09-0.11) 0.18 (0.16-0.20) 
Masters or PhD 16.5% (n=332) 0.07 (0.06-0.09) 0.14 (0.13-0.17) 
Maternal Education p<0.0001 p<0.0001 
Highschool or less 6.6% (n=133) 0.30 (0.21-0.42) 0.75 (0.52-1.08) 
Some Post-Secondary 14.0% (n=282) 0.18 (0.14-0.22) 0.35 (0.28-0.44) 
Completed Post-
Secondary 
59.3% (n=1196) 0.10 (0.09-0.11) 0.20 (0.18-0.22) 
Masters or PhD 20.1% (n=406) 0.09 (0.08-0.10) 0.16 (0.14-0.19) 
Parental History A vs. no A p=0.03 
ATP vs. no ATP 
p=0.19 
A vs. no A p=0.11 
ATP vs. no ATP p=0.02 
Asthma (A) 31.3% (n=660) 0.13 (0.12-0.15) 0.24 (0.21-0.27) 
No Asthma 67.3% (n=1357) 0.11 (0.10-0.12) 0.22 (0.20-0.24) 
Atopy (ATP) 79.9% (n=1611) 0.11 (0.11-0.12) 0.22 (0.20-0.23) 
No Atopy 20.1% (n=406) 0.13 (0.11-0.15) 0.26 (0.22-0.31) 
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Month of Birth p=0.18 p=0.22 
January 8.4% (n=170) 0.11 (0.09-0.14) 0.20 (0.15-0.25) 
February 7.6% (n=153) 0.14 (0.11-0.18) 0.24 (0.18-0.33) 
March 9.9% (n=200) 0.12 (0.10-0.15) 0.24 (0.19-0.30) 
April 8.9% (n=179) 0.12 (0.10-0.16) 0.26 (0.20-0.33) 
May 9.0% (n=182) 0.12 (0.10-0.15) 0.23 (0.18-0.28) 
June 9.1% (n=184) 0.10 (0.08-0.13) 0.23 (0.18-0.29) 
July 8.2% (n=166) 0.12 (0.08-0.16) 0.27 (0.19-0.36) 
August 7.2% (n=145) 0.12 (0.09-0.15) 0.26 (0.19-0.35) 
September 6.9% (n=140) 0.13 (0.09-0.18) 0.21 (0.15-0.30) 
October 7.7% (n=156) 0.09 (0.07-0.12) 0.16 (0.13-0.19) 
November 8.9% (n=179) 0.12 (0.10-0.15) 0.20 (0.16-0.25) 
December 8.1% (n=163) 0.11 (0.08-0.14) 0.23 (0.17-0.30) 
Season of sample Collection p=0.01 p=0.0008 
Summer 24.7% (n=498) 0.13 (0.11-0.15) 0.26 (0.22-0.30) 
Fall 23.2% (n=467) 0.11 (0.09-0.13) 0.24 (0.20-0.27) 
Winter 23.8% (n=481) 0.11 (0.09-0.13) 0.20 (0.17-0.24) 
Spring 28.3% (n=571) 0.12 (0.10-0.13) 0.21 (0.18-0.24) 
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Maternal Ethnicity p=0.0001 p<0.0001 
Caucasian/White 74.8% (n=1509) 0.11 (0.11-0.12) 0.22 (0.20-0.24) 
East Asian 6.3% (n=127) 0.09 (0.07-0.11) 0.13 (0.11-0.17) 
South East Asian 4.8% (n=97) 0.13 (0.10-0.18) 0.20 (0.14-0.28) 
Multiracial 4.1% (n=82) 0.10 (0.08-0.15) 0.22 (0.15-0.33) 
First Nations 3.4% (n=69) 0.39 (0.23-0.65) 1.02 (0.57-1.82) 
South Asian 2.6% (n=53) 0.09 (0.06-0.13) 0.22 (0.13-0.34) 
Hispanic 1.5% (n=31) 0.10 (0.06-0.17) 0.16 (0.10-0.26) 
Black 1.3% (n=27) 0.12 (0.08-0.18) 0.28 (0.17-0.45) 
Middle Eastern 0.9% (n=19) 0.09 (0.05-0.15) 0.24 (0.14-0.42) 
Unknown/Other 0.1% (n=3) 0.07 (0.003-1.46) 0.21 (0.01-3.49) 
Paternal Ethnicity p=0.002 p<0.0001 
Caucasian/White 75.4%(n=1521) 0.11 (0.10-0.12) 0.21 (0.20-0.23) 
East Asian 4.7% (n=95) 0.09 (0.07-0.12) 0.13 (0.10-0.18) 
South East Asian 3.9% (n=79) 0.10 (0.07-0.14) 0.16 (0.12-0.22) 
Multiracial 3.4% (n=68) 0.12 (0.08-0.18) 0.24 (0.17-0.36) 
First Nations 3.7% (n=75) 0.28 (0.18-0.45) 0.65 (0.38-1.09) 
South Asian 3.5% (n=70) 0.11 (0.08-0.15) 0.22 (0.15-0.32) 
Hispanic 1.5% (n=31) 0.12 (0.06-0.25) 0.23 (0.11-0.48) 
Black 2.1% (n=45) 0.18 (0.09-0.33) 0.65 (0.32-1.33) 
Middle Eastern 1.0% (n=20) 0.08 (0.05-0.12) 0.19 (0.12-0.30) 
Unknown/Other 0.6% (n=13) 0.25 (0.07-0.85) 0.52 (0.12-2.17) 
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Maternal Age at Enrolment p<0.0001 p<0.0001 
17 to 23 years old 3.8% (n=77) 0.42 (0.28-0.64) 1.01 (0.64-1.60) 
24 to 30 years old 32.2% (n=649) 0.14 (0.12-0.16) 0.29 (0.25-0.33) 
31 to 35 years old 41.9% (n=845) 0.10 (0.09-0.11) 0.19 (0.17-0.21) 
36-46 years old 22.1% (n=446) 0.09 (0.08-0.11) 0.17 (0.15-0.20) 
Study Centre p=0.00005 p<0.0001 
Vancouver 26.7% (n=539) 0.10 (0.09-0.12) 0.16 (0.14-0.18) 
Edmonton 19.9% (n=402) 0.13 (0.11-0.15) 0.28 (0.23-0.34) 
Winnipeg,Morden, or 
Winkler  
30.9% (n=624) 0.14 (0.12-0.16) 0.29 (0.25-0.34) 
Toronto 22.4% (n=452) 0.09 (0.08-0.10) 0.20 (0.17-0.22) 
Breastfeeding Status p=0.005 p=0.16 
None 12.0% (n=243) 0.16 (0.13-0.19) 0.29 (0.23-0.36) 
Partial 25.8% (n=520) 0.12 (0.10-0.14) 0.24 (0.20-0.28) 
Exclusive 62.2% (n=1254) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Infant’s 3-month Diet p=0.04 p=0.18 
Breastfeeding Only 62.2% (n=1254) 0.11 (0.10-0.12) 0.21 (0.19-0.23) 
Breastfeeding and 
Formula 
24.2% (n=489) 0.12 (0.10-0.14) 0.24 (0.20-0.28) 
Breastfeeding and Solid 
Food 
0.9% (n=18) 0.13 (0.04-0.37) 0.34 (0.11-1.02) 
Formula Only 11.2% (n=226) 0.15 (0.12-0.19) 0.27 (0.21-0.34) 
Formula and Solid Food 0.8% (n=17) 0.27 (0.09-0.77) 0.71 (0.23-2.17) 
Breastfeeding, Formula, 
and Solid Food 
0.6% (n=13) 0.12 (0.05-0.28) 0.20 (0.06-0.63) 
The proportion and crude number of sample subjects that corresponds to each level of household characteristic 
variables is reported to the nearest whole number. The geometric mean (95% Confidence interval) of the corrected and 
log-transformed Cotinine distribution for each level of each variable is also reported to the nearest two decimal places. 




Figure A.2a. Variable importance plot for cotinine concentration 
Variables with higher importance scores (top right) in predicting the distribution of the log-
transformed trans-3’-hydroxycotinine concentration (ng/mL) were found through random forest 
regression. Variables related to second-hand smoke (green), household characteristics or third-
hand smoke reservoirs (blue), and other (red). 
Maternal Smoking status prior to pregnancy 
Cigarettes smoked daily at the home, early life 
How often did the mother smoke during pregnancy 
Days mother exposed to smoke during pregnancy, past 2 wks 
Week Gestation that mother quit smoking 
Cigarettes smoked daily by mother during pregnancy 
Cigarettes smoked daily at the home, during pregnancy 
Household smoking in early life 
Mother quit smoking during pregnancy 
Cigarettes smoked during pregnancy pre-quitting 
Household smoking during pregnancy 
Household smoker smokes inside during pregnancy 
Household smoker smokes outside, early life 
Household smoker smokes outside during pregnancy 
Household smoking near window/garage during pregnancy  
Household Income 
Breastfeeding status at 3 months 
Number of smokers at the home during pregnancy 
Hours pregnant mother is exposed daily 
Study Centre 
Household smoker present during pregnancy 
Mother reduced smoking during pregnancy 
Dwelling type, 6 groups 
Days infant exposed to smoke in past week, 3mo 
Parental history of asthmatic disease 
Cigarettes smoked daily prior to reducing, in pregnancy 
Basement has area rug 
Week Gestation that mother reduced smoking (grouped) 
Father’s highest level of education 
Age that the mother started smoking 
Any recent smoke exposure during pregnancy 
Dwelling type, 3 groups 
Number of bedrooms in the home 
Basement is carpeted 
Primary living space is carpeted 
Breastfeeding status, including in hospital 
Infant diet 
Week Gestation that mother reduced smoking(numeric) 
Mother’s age at enrolment 
Hours infant exposed to smoke in past week, 3mo  
Presence and type of air conditioning, early life 
Age mother quit smoking prior to pregnancy 
Home ownership 
Child’s bedroom is carpeted 
Has the mother ever smoked for 1+ year? 
Cigarettes smoked daily prior to quitting in pregnancy 
Kitchen has an area rug 
Single or Multi-family home 
Season at sample collection 
Mother’s highest level of education 
Number of cars owned or leased 
Air conditioner use during Summer months 
Any smoke exposure to baby since birth 
Month of sample collection 
Mom’s bedroom has an area rug 
Tobacco smell detected in garage 
Maternal ethnicity 
Cotinine concentration was below LOD 
Living space has an area rug 
Parental atopy status 
Bathroom has an area rug 
Child’s ethnicity (derived) 
Mom’s bedroom is carpeted 
Child’s bedroom has an area rug 
Bathroom was carpeted 
Household smoking near window/garage, early life 
Infant’s birthweight 
Child’s month of birth 
Paternal ethnicity 
Frequency of taking folate supplements 
Household smoking inside, early life 
Mother takes folate supplements 
Child’s sex 




Figure A.2b. Variable importance plot for trans-3’-hydroxycotinine concentration 
Variables with higher importance scores (top right) in predicting the distribution of the log-
transformed trans-3’-hydroxycotinine concentration (ng/mL) were found through random forest 
regression. Variables related to second-hand smoke (green), household characteristics or third-
hand smoke reservoirs (blue), and other (red). 
Maternal Smoking status prior to pregnancy 
Cigarettes smoked daily at the home, early life 
Days mother exposed to smoke during pregnancy, past 2 wks 
How often did the mother smoke during pregnancy 
Cigarettes smoked daily at the home, during pregnancy 
Week Gestation that mother quit smoking 
Household smoking in early life 
Household smoking outside, early life 
Cigarettes smoked daily by mother during pregnancy 
Household smoking inside during pregnancy  
Household smoking during pregnancy  
Mother quit smoking during pregnancy 
Household smoking near window/garage during pregnancy  
Household smoking outside during pregnancy  
Breastfeeding status at 3 months 
Mother reduced smoking during pregnancy 
Cigarettes smoked during pregnancy pre-quitting 
Hours pregnant mother is exposed daily 
Study Centre 
Number of smokers at the home during pregnancy 
Cigarettes smoked daily prior to quitting in pregnancy 
Child’s bedroom is carpeted 
Mom’s bedroom is carpeted 
Days infant exposed to smoke in past week, 3mo 
Hours infant exposed to smoke in past week, 3mo  
Father’s highest level of education 
Household smoker present during pregnancy 
Age that the mother started smoking 
Season at sample collection 
Infant diet 
Child’s month of birth 
Mother’s highest level of education 
Week Gestation that mother reduced smoking (grouped) 
Home ownership 
Breastfeeding status, including in hospital 
Cigarettes smoked daily prior to reducing, in pregnancy 
Dwelling type, 6 groups 
Primary living space is carpeted 
Week Gestation that mother reduced smoking(numeric) 
Age mother quit smoking prior to pregnancy 
Any recent smoke exposure during pregnancy 
Household Income 
Paternal ethnicity 
Has the mother ever smoked for 1+ year? 
Basement is carpeted 
Child’s bedroom has an area rug 
Month of sample collection 
Any smoke exposure to baby since birth 
Dwelling type, 3 groups 
Living space has an area rug 
Mother’s age at enrolment 
Presence and type of air conditioning, early life 
Maternal ethnicity 
Number of cars owned or leased 
Household smoking near window/garage, early life 
Kitchen has an area rug 
Air conditioner use during Summer months 
Bathroom was carpeted 
Basement has area rug 
Parental history of asthmatic disease 
Single or Multi-family home 
Mom’s bedroom has an area rug 
Bathroom has an area rug 
Household smoking inside, early life 
Number of bedrooms in the home 
Child’s sex 
Parental atopy status 
Kitchen is carpeted 
Child’s ethnicity (derived) 
Tobacco smell detected in garage 
Frequency of taking folate supplements 




Table A.2. Variable Importance and R2 Scores for Potential Predictors 
 














Status Prior to 
Pregnancy 
23.10 18.8 22.49 22.9 
Cigarettes smoked daily 
at home in early life  
18.92 14.4 19.96 18.3 
Frequency of maternal 
smoking during 
pregnancy 
18.70 16.0 16.99 18.1 
Days pregnant mother 
has been exposed to 
tobacco smoke in the 
past 2 weeks 
18.47 15.3 17.49 18.1 
Week of gestation mother 
quit smoking during 
pregnancy 
16.93 9.3 15.35 11.8 
Average Cigarettes 
Smoked in Pregnancy 
16.15 15.6 14.76 17.6 
Average Daily Cigarettes 
Smoked at Home in 
Pregnancy 
14.13 14.3 15.74 17.7 
Household Smoking 
since birth 
13.56 11.0 15.31 15.3 
Maternal Smoking Status 
during pregnancy 
11.44 14.8 13.26 18.6 
Average Daily Cigarettes 
during Pregnancy before 
quitting 
11.07 6.9 8.82 9.1 
Household Smoking 
during pregnancy 
11.06 11.3 13.31 14.6 
Household smoking 
indoors during pregnancy 
10.96 12.5 13.61 15.8 
Household smoking 
outside since birth 
10.69 8.0 14.92 11.5 
Household smoking 
outside during pregnancy 

















Household smoking near 
window or in garage 
during pregnancy 
10.53 11.5 12.26 14.9 
Household Income 9.74 4.6 5.00 5.4 
Breastfeeding Status 8.93 0.5 10.66 0.4 
Number of Household 
Smokers, Prenatal 
8.33 6.6 8.83 8.2 
Hours of exposure, past 2 
weeks of pregnancy 
8.25 4.3 9.28 5.4 
Centre 8.19 1.1 9.23 2.3 
Frequency of a 
household smoker in 
pregnancy 
7.79 6.5 7.19 8.2 
Cut down smoking during 
pregnancy 
7.52 15.0 9.76 18.1 
Dwelling Type, 7 groups 7.46 1.6 5.70 1.8 
Days baby exposed in 
past week 
7.44 3.3 7.23 4.7 
Parental Asthma 7.32 0.2 1.09 0.1 
Daily cigarettes before 
cutting down in 
pregnancy 
6.99 11.5 5.95 13.0 
Area rug in basement 6.62 0.8 1.29 0.6 
Week Reduced Smoking 
during pregnancy 
5.95 11.9 5.97 13.4 
Paternal Education 5.77 5.3 7.63 7.1 
Age Started Smoking 5.53 7.0 6.73 9.6 
Recent prenatal smoke 
exposure 
5.51 8.4 5.07 10.6 
Dwelling Type, 3 groups 5.38 1.2 3.08 1.3 

















Carpeted basement 5.30 0.8 4.38 0.6 
Carpeted living space 5.28 0.1 5.43 0.03 
Hospital Breastfeeding 
Status 
5.15 0.5 5.95 0.5 
Infant Diet 4.86 0.6 6.58 0.7 
Week gestation reduced 
smoking, numeric 
4.86 8.3 5.39 9.6 
Maternal Age 4.83 3.5 3.02 4.7 
Hours baby exposed in 
past week of life 
4.65 3.2 7.70 4.6 
Air conditioning 4.35 1.3 3.02 1.7 
Age quit prior to 
pregnancy 
4.12 0.2 5.37 0.3 
Home Ownership 3.75 2.5 5.96 2.3 
Carpeted child’s room 3.67 1.0 8.66 1.5 
Ever smoked for 1 year 3.52 6.6 4.51 9.4 
Average cigarettes prior 
to quitting 
3.29 0.2 9.45 0.4 
Area rug in kitchen 3.01 <0.001 1.80 0.04 
Home Type 2.95 0.2 0.97 0.2 
Collection Season 2.93 0.2 6.71 0.3 
Maternal Education 2.75 3.8 6.22 5.2 
Number of cars  2.72 0.8 1.99 1.2 
Summer air conditioning 2.51 0.04 1.73 0.1 
Any exposure to baby 2.30 2.6 3.38 4.4 
Collection Month 1.88 0.7 3.49 0.8 
Area rug in mom’s 
bedroom 

















Tobacco Smell in Garage 1.78 1.9 -2.47 2.5 
Maternal ethnicity 1.67 2.3 2.45 3.4 
Area rug in living space 1.42 0.09 3.03 0.3 
Parental Atopy 1.40 0.05 -0.31 0.2 
Area rug in bathroom 1.32 0.1 0.41 0.4 
Child’s ethnicity 1.26 1.4 -0.83 2.5 
Carpeted mom’s room 1.19 0.06 7.80 0.2 
Area rug in child’s room 0.90 1.0 4.14 1.6 
Carpeted bathroom 0.90 <0.001 1.63 <0.001 
Household smoking near 
a window or in the 
garage, early life 
0.75 3.5 1.87 4.7 
Birthweight 0.66 0.07 -4.32 <0.001 
Month of birth -0.06 0.4 6.47 0.6 
Paternal ethnicity -0.29 1.6 4.66 3.1 
Folate Supplements, 
numeric 
-0.71 0.02 -2.64 <0.001 
Household smoking 
inside, early life 
-0.76 1.5 0.12 1.9 
Folate Supplements -0.91 0.06 -3.86 0.06 
Child’s sex -1.16 0.03 -0.15 <0.001 
Carpeted kitchen -2.92 0.1 -0.72 <0.001 
Predictor Variables are ordered from highest (top) to lowest (bottom) variable importance against log-transformed 
cotinine concentration, as determined through random forest regression. Importance scores are reported to the nearest 
2 decimal places and reflect either the percentage of increase in mean squared error (%MSE) the average model will 
incur should the predictor be excluded from the model. R2 values are reported as a percentage based on bivariate 





Figure A.3a. Distribution of log-transformed Cotinine concentration following 
imputation of concentrations below detection 
The post-imputation distribution ranges from -10.49 to 7.41, which equates to an original 
concentration range from 0.0007 to 170.0 ng/mL. The imputed cotinine concentrations ranged 
from -10.49 to -5.06 which equates to an original concentration of 0.0007 to 0.02997 ng/mL, 
consistent with our range of 0-0.03ng/mL. The Median concentration of the original cotinine 





Figure A.3b. Distribution of log-transformed Hydroxycotinine concentration 
following imputation of concentrations below detection 
The post-imputation distribution ranges from -8.49 to 10.30, which equates to an original 
concentration range from 0.0028 to 1260.0 ng/mL. The imputed hydroxycotinine concentrations 
ranged from a raw concentration of 0.0004 to 0.0299 ng/mL, consistent with our range of 0-
0.03ng/mL. The Median concentration of the original cotinine concentrations was 0.0141 ng/mL, 





Table A.3. Predictor data dictionary 







 The mother’s smoking 
status prior the pregnancy 
3 groups; 
• Never smoked 
• Quit prior to the 
pregnancy 







during pregnancy  
 How often the mother 










mother has been 
exposed to 
tobacco smoke in 
the past 2 weeks  
Average number of days 
the pregnant mother was 
exposed to tobacco smoke 
in the past 2 weeks  










 Week of gestation that the 
mother quit smoking during 
her pregnancy  









Average number of 
cigarettes the pregnancy 
mother smoked per day 
3 groups; 
• None 
• Less than 10/day 






Smoked at Home 
in Pregnancy  
 The average number of 
cigarettes/cigars/pipes 




• Less than 1/day 
• 1-5/day 
• 6-10 /day 







Whether or not anyone 
smokes at the home since 







parent(s) at 3-4 





Average number of 
cigarettes the pregnancy 
mother smoked per day 
prior to quitting 
4 groups; 
• Never Smoke 
• Less than 5/day 
• 5-10/day 






Predictor Description Levels or range of 
responses 
Collection method 
Household Income  Parental response to “What 
is the best estimate of total 
income, before taxes and 
deductions, of all household 
members, from all sources 
















 Status of infants 
breastfeeding at 3 months 
of age 
3 levels; 
• Not breastfed (no 
recorded initiation of 
breastfeeding in 
hospital) 
• Partially breastfed 








human milk, juice) 
or food) is 
introduced.) 
Determined using a 
combination of the 
birth and nutrition 
questionnaires 











parents when child 
is 3-4 months of age 
Frequency of a 
household smoker 
in pregnancy 
 Whether and how frequent 
anyone smoked inside the 









Parental Asthma  Whether or not at least one 
parent has a history or 
current diagnosis of 
asthma. If one parent was 
missing, and the other had 
a positive response, the 
child was positive. If both 
had no response, or if one 
was a no and the other 
missing, the child did not 




If both parents' results 
were missing, the 
child was not 











 Highest level of education 
achieved by the father  
4 levels; 











Dwelling Type, 3 
groups 
 The type of dwelling that 



















Week of gestation that the 
mother reduced smoking 
during her pregnancy 





Home Ownership  Questionnaire response to 













Research staff indication of 
whether or not the child’s 
bedroom had installed 










research staff at 3-4 
months of age 
Collection Season  Season of urine sample 
collection. Derived from the 
month when urine samples 
were collected. 










at the 3-4month of 
age home 
assessment 
This table offers an explanation of how each of the variables in our final predictor models (Tables 3a and 3b of main 




Table A4.  Cotinine Multivariable Linear Regression Model and Multiplicative Change in log-transformed Cotinine 
concentrations 




in Concentration  
(95% CI) 











R2* (%)  
31.43 
Mother’s Smoking Prior to Pregnancy   18.83    
Did not quit smoking prior to pregnancy vs. Never 
Smoked 
4.30 (3.91, 4.69) 19.72 (15.05-24.86)  1.24 (0.58, 1.90) 2.2.36 (1.49-3.74)  
Quit Smoking prior to pregnancy vs. Never Smoked 0.42 (0.18, 0.67) 1.34 (1.13-1.59)  0.17 (-0.06, 0.40) 1.13 (0.96-1.32)  
Mother’s Reported Smoking Frequency in Pregnancy  16.0    
Smoked daily or occasionally vs. Never Smoked 4.30 (3.87, 4.74) 19.76 (14.66-26.64)  2.20 (1.53, 2.87) 4.59 (2.89-7.29)  
Days Exposed to Cigarette Smoke in past 2 weeks during pregnancy  15.25    
Continuous 0.29 (0.26, 0.32) 1.22 (1.20-1.25)  0.07 (0.03, 0.10) 1.05 (1.02-1.07)  
Week of gestation when mother quit smoking  7.79    
Continuous 0.33 (0.28, 0.38) 1.26 (1.21-1.30)  0.14 (0.08, 0.21) 1.10 (1.05-1.15)  
Week of gestation when mother cut down smoking  8.31    
Continuous 0.49 (0.42, 0.56) 1.40 (1.34-1.47)  -0.08 (-0.17, -0.01) 0.95 (0.89-1.01)  
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in Concentration  
(95% CI) 











R2* (%)  
31.43 
Average Daily Cigarettes Smoked at the Home during pregnancy  14.27    
Less than 1/day vs None  3.63 (3.11, 4.15) 12.41 (8.66-17.79)  0.64 (0.03, 1.25) 1.56 (1.02-2.37)  
1-5/day vs None 0.33 (-0.18, 0.83) 1.25 (0.89-1.78)  -0.54 (-1.03, -0.06) 0.69 (0.49-0.96)  
6-10/day vs None 0.38 (-0.23, 0.99) 1.30 (0.85-1.98)  0.15 (-0.40, 0.70) 1.11 (0.76-1.63)  
11+/day vs None -0.19 (-0.74, 0.35) 0.88 (0.60-1.28)  -0.11 (-0.61, 0.39) 0.93 (0.66-1.31)  
Has anyone smoked at the baby’s home since their birth?  10.97    
Yes vs. No 2.39 (2.10, 2.69) 5.26 (4.28-6.46)  0.31 (-0.19, 0.80) 1.24 (0.88-1.74)  
Average Daily Cigarettes Smoked at the Home since child’s birth  14.37    
1-5/day vs. None 3.61 (3.07, 4.15) 12.23 (8.41, 17.77)  0.77 (0.10, 1.43) 1.70 (1.08, 2.69)  
6-10/day vs. None -0.48 (-1.05, 0.08) 0.72 (0.48, 1.06)  0.03 (-0.54, 0.60) 1.02 (0.69, 1.51)  
11+/day vs. None 0.01 (-0.57, 0.60) 1.01 (0.67, 1.51)  0.17 (-0.38, 0.71) 1.12 (0.77, 1.64)  
Breastfeeding status at 3 months   0.48    
Partially vs. Exclusively Breastfed 0.36 (0.13, 0.59) 1.29 (1.10-1.51)  -0.28 (-0.48, -0.08) 0.82 (0.72-0.95)  
Never vs. Exclusively Breastfed 0.13 (-0.08, 0.34) 1.10 (0.95-1.27)  -0.09 (-0.27, 0.09) 0.94 (0.83-1.07)  
Dwelling Type   1.23    
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in Concentration  
(95% CI) 











R2* (%)  
31.43 
Multi-family vs. single-family Home 0.83 (0.18, 1.47) 1.77 (1.13-2.77)  0.19 (-0.36, 0.75) 1.14 (0.78-1.68)  
Trailer/other vs. single-family Home 0.04 (-0.37, 0.44) 1.03 (0.77-1.36)  -0.16 (-0.51, 0.19) 0.89 (0.70-1.14)  
Household Income   4.60    
$50,000-99,999/year vs. <$50,000/year -0.96 (-1.26, -0.65) 0.52 (0.42-0.64)  -0.45 (-0.72, -0.18) 0.73 (0.61-0.88)  
$100,000-149,999/year vs. <$50,000/year 0.90 (0.62, 1.18) 1.87 (1.54-2.27)  0.31 (-0.06, 0.56) 1.24 (1.04-1.47)  
$150,000+/year vs. <$50,000/year 0.18 (-0.05, 0.41) 1.13 (0.97-1.33)  0.08 (-0.12, 0.27) 1.05 (0.92-1.21)  
Prefers not to say vs. <$50,000/year 0.06 (-0.14, 0.26) 1.04 (0.91-1.20)  -0.06 (-0.23, 0.11) 0.96 (0.85-1.08)  
Paternal Education   5.29    
Some post-secondary vs. Highschool or less -1.37 (-1.63, -1.11) 0.39 (0.32-0.46)  -0.37 (-0.62, -0.13) 0.77 (0.65-0.92)  
Completed post-secondary vs. Highschool or less 0.13 (-0.11, 0.36) 1.09 (0.93-1.29)  -0.16 (-0.37, 0.04) 0.89 (0.77-1.03)  
Masters or PhD vs. Highschool or less 0.04 (-0.16, 0.25) 1.03 (0.89-1.19)  0.05 (-0.13, 0.23) 1.04 (0.92-1.17)  
Parental History of Asthma   0.25    
Yes vs. No 0.25 (0.03, 0.47) 1.19 (1.02-1.39)  0.22 (0.03, 0.41) 1.16 (1.02-1.32)  
Estimated change in log-transformed metabolite level by predictors in unadjusted regression models (95% confidence intervals), as well as the coinciding R2 values are shown to 
the nearest second decimal place. * Estimated change in log-transformed metabolite level by predictors in adjusted final regression models (95% confidence intervals), as well as 
the coinciding R2 values are shown to the nearest second decimal place. 
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Table A5.  Trans-3’-Hydroxycotinine Multivariable Linear Regression Model and Multiplicative Change in log-transformed 
trans-3’-Hydroxycotinine concentrations 




















Mother’s Smoking Prior to Pregnancy   22.90    
Did not quit smoking prior vs. Never Smoked 4.95 (4.55, 5.35) 30.86 (23.40-40.68)  1.99 (1.09, 2.88) 3.97 (2.13-7.37)  
Quit Smoking prior vs. Never Smoked 0.68 (0.43, 0.93) 1.60 (1.35-1.90)  0.45 (0.23, 0.68) 1.37 (1.17-1.60)  
Average Cigarettes Smoked Daily Prior to Quitting During Pregnancy  9.11    
Less than 5/day vs. Never Smoked  3.61 (2.91, 4.31) 12.20 (7.49-19.88)  0.65 (-0.32, 1.62) 1.57 (0.80-3.07)  
5 to 10/day vs. vs. Never Smoked  -0.54 (-1.31, 0.23) 0.69 (0.40-1.17)  1.60 (0.78, 2.43) 3.03 (1.72-5.38)  
11 to 25/day vs. Never Smoked 0.50 (-0.32, 1.32) 1.42 (0.80-2.50)  -0.21 (-0.91, 0.49) 0.86 (0.53-1.40)  
Mother’s Reported Smoking Frequency in Pregnancy  18.11    
Smoked daily or occasionally vs. Never Smoked 4.80 (4.35, 5.24) 27.77 (20.39-37.81)  3.13 (1.16, 5.10) 8.73 (2.22-34.21)  
Average Cigarettes Smoked by Mother in early pregnancy  17.56    
Less than 10/day vs. None 5.39 (4.67, 6.11) 42.01 (25.51-69.20)  -0.60 (-2.72, 1.53) 0.66 (0.15-2.88)  
10-20/day vs. None -1.97 (-2.75, -1.18) 0.26 (0.15-0.44)  1.58 (0.25, 2.91) 2.98 (1.19-7.50)  
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Days Exposed to Cigarette Smoke in past 2 weeks during pregnancy  18.08    
Continuous 0.33 (0.30, 0.36) 1.26 (1.23-1.29)  0.05 (0.01, 0.10) 1.04 (1.01-1.07)  
Mother had any recent tobacco smoke exposure during pregnancy  10.58    
Recent exposure 1.98 (1.73, 2.23) 3.94 (3.31-4.68)  0.24 (-0.07, 0.54) 1.17 (0.95-1.46)  
Week of gestation when mother quit smoking   9.80    
Continuous 0.39 (0.34, 0.44) 1.30 (1.26-1.35)  0.16 (0.08, 0.25) 1.12 (1.06-1.19)  
Did anyone smoke at the baby’s home during pregnancy? 8.91     
Occasionally vs. None 3.54 (2.74, 4.33) 11.60 (6.68-20.12)  0.16 (-0.54, 0.87) 1.12 (0.69-1.83)  
Regularly vs. None 4.93 (4.00, 5.86) 30.41 (15.87-58.25)  0.54 (-0.37, 1.44) 1.45 (0.78-2.71)  
Average Daily Cigarettes Smoked at the Home during pregnancy  17.69    
Less than 1/day vs None  4.07 (3.54, 4.61) 16.85 (11.64-24.37)  0.21 (-0.44, 0.86) 1.16 (0.74-1.81)  
1-5/day vs None 0.24 (-0.28, 0.75) 1.18 (0.82-1.69)  -0.85 (-1.36, -0.34) 0.56 (0.39-0.79)  
6-10/day vs None 0.61 (-0.02, 1.23) 1.52 (1.00-2.34)  0.23 (-0.33, 0.79) 1.17 (0.79-1.73)  
11+/day vs None -0.13 (-0.69, 0.43) 0.91 (0.62-1.34)  0.09 (-0.40, 0.58) 1.06 (0.76-1.50)  
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Has anyone smoked at the baby’s home since their birth?  15.27    
Yes vs. No 2.96 (2.65, 3.26) 7.77 (6.30-9.60)  0.70 (0.22, 1.19) 1.63 (1.16-2.28)  
Average Daily Cigarettes Smoked at the Home since child’s birth  18.32    
1-5/day vs. None 4.03 (3.48, 4.58) 16.37 (11.17-24.00)  0.41 (-0.24, 1.07) 1.33 (0.85-2.10)  
6-10/day vs. None -0.80 (-1.37, -0.22) 0.58 (0.39-0.86)  -0.12 (-0.68, 0.45) 0.92 (0.62-1.36)  
11+/day vs. None 0.11 (-0.49, 0.71) 1.08 (0.71-1.63)  0.24 (-0.30, 0.78) 1.18 (0.81-0.72)  
Carpeting in the home   1.53    
Child’s room is not carpeted vs. No child-specific room -0.59 (-0.81, -0.38) 0.66 (0.57-0.77)  -0.18 (-0.37, -0.0) 0.88 (0.78-1.00)  
Child’s room is carpeted vs. No child-specific room 0.27 (0.09, 0.46) 1.21 (1.06-1.37)  -0.05 (-0.20, 0.11) 0.97 (0.87-1.08)  
Breastfeeding status at 3 months   0.39    
Partially vs. Exclusively Breastfed 0.32 (0.08, 0.56) 1.25 (1.06-1.48)  -0.52 (-0.72, -0.32) 0.70 (0.61-0.80)  
Not vs. Exclusively Breastfed 0.03 (-0.19, 0.25) 1.02 (0.88-1.19)  -0.29 (-0.47, -0.12) 0.82 (0.72-0.92)  
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Dwelling Type   1.29    
Multi-family vs. single-family Home 0.99 (0.31, 1.66) 1.98 (1.24-3.17)  0.30 (-0.25, 0.84) 1.23 (0.84-1.79)  
Trailer/other vs. single-family Home 0.12 (-0.31, 0.54) 1.08 (0.81-1.46)  -0.23 (-0.59, 0.12) 0.85 (0.66-1.09)  
Home Ownership   2.31    
Rents vs. Owns Home 0.89 (0.64, 1.15) 1.86 (1.56-2.21)  -0.02 (-0.26, 0.22) 0.99 (0.84-1.17)  
Household Income   5.42    
$50,000-99,999/year vs. <$50,000/year -0.93 (-1.25, -0.61) 0.52 (0.42-0.65)  -0.34 (-0.62, -0.07) 0.79 (0.65-0.95)  
$100,000-149,999/year vs. <$50,000/year 1.18 (0.89, 1.47) 2.26 (1.85-2.77)  0.38 (0.13, 0.64) 1.31 (1.09-1.56)  
$150,000+/year vs. <$50,000/year 0.22 (-0.02, 0.46) 1.17 (0.99-1.37)  0.05 (-0.14, 0.25) 1.04 (0.91-1.19)  
Prefers not to say vs. <$50,000/year 0.24 (0.03, 0.45) 1.18 (1.02-1.36)  0.11 (-0.06, 0.28) 1.08 (0.96-1.21)  
Collection Season   0.32    
Spring vs. Fall -0.18 (-0.49, 0.12) 0.88 (0.71-1.08)  -0.34 (-0.58, -0.10) 0.80 (0.67-0.93)  
Summer vs. Fall 0.13 (-0.18, 0.45) 1.10 (0.88-1.36)  0.18 (-0.06, 0.43) 1.13 (0.96-1.34)  
Winter vs. Fall -0.21 (-0.52, 0.11) 0.87 (0.70-1.08)  -0.32 (-0.57, -0.07) 0.80 (0.67-0.95)  
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Study Centre   2.30    
Toronto vs. Edmonton -0.50 (-0.83, -0.17) 0.71 (0.56-0.89)  -0.11 (-0.40, 0.17) 0.92 (0.76-1.12)  
Vancouver vs. Edmonton -0.82 (-1.14, -0.51) 0.57 (0.45-0.70)  -0.59 (-0.86, -0.31) 0.67 (0.55-0.80)  
Winnipeg vs. Edmonton 0.06 (-0.24, 0.37) 1.05 (0.84-1.29)  -0.15 (-0.40, 0.10) 0.90 (0.76-1.07)  
Paternal Education   7.05    
Some post-secondary vs. Highschool or less -1.58 (-1.85, -1.31) 0.33 (0.28-0.40)  -0.45 (-0.70, -0.20) 0.73 (0.62-0.87)  
Completed post-secondary vs. Highschool or less 0.23 (0.02, 0.47) 1.17 (0.99-1.39)  -0.11 (-0.31, 0.10) 0.93 (0.81-1.07)  
Masters or PhD vs. Highschool or less 0.18 (-0.03, 0.40) 1.14 (0.98-1.32)  0.20 (0.25, 0.37) 1.15 (1.02-1.30)  
Estimated change in log-transformed metabolite level by predictors in unadjusted regression models (95% confidence intervals), as well as the coinciding R2 values are shown to 
the nearest second decimal place.* Estimated change in log-transformed metabolite level by predictors in adjusted final regression models (95% confidence intervals), as well as 
the coinciding R2 values are shown to the nearest second decimal place. 
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Figure B.1. Sample Selection Flow Chart 
Of the 3,455 children in the CHILD Study, 2,607 had urine samples collected at 3 months of age. 2,607 urine samples are available, with 2,509 of 
these samples having detectable levels of our biomarkers available for analysis. We examined 2,570 urine samples taken at 3-4 months of age to 
measure cotinine and trans-3’-hydroxycotinine (3HC), and a combination of both. A subset of these who have complete data of relevant 
demographic, socioeconomic, exposure, diet, and health outcome data were selected as the current sample size. Of the final 1,432 subjects with 
metabolite data, 361 (25.2%) had a cotinine concentration below the LOD, and 162 (11.3%) had a 3HC concentration below the LOD that were 
imputed prior to analysis.










































Figure B.2 Scatterplots of the association between maternal dietary nicotine 
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Maternal Dietary Nicotine and Infant's Cotinine Concentration, Subset
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*CHILD variable Calculations 
Peeled tomato 
sold in cans; 
tomatoes 








<- ripe, fresh 
130g per 125mL 




3.9 ug/kg * 1000 ng/ug * kg/1000g 
= 3.9 ng/g 
3.9 ng/g * 123 g/portion = 479.7 
ng/portions 
479.7 ng/portion * portions/meal * 













130g per 125mL (6.2+4.5)/2 = 5.35 
5.35 ng/g * 130 g/portion = 695.5 
ng/portions 
695.5 ng/portion * portions/meal * 









130g per 125mL  
*Ffrq48 (Spaghetti 
and other pasta 
with tomato and 
meat sauce) 
Ketchup sold 
in glass or 
plastic 










7.3 ng/g * 30 g/portion = 219 
ng/portions 
219 ng/portion * portions/meal * 
frequency eaten/week = _ng 
intake/week 














*CHILD variable Calculations 
*Ffrq92 (French 
fries, fried potatoes 
and hash browns) 
441.6 ng/portion * portions/meal * 

















156 per baked 
potato (173 with 
skin 
*Ffrq93 (Potatoes -
boiled, baked or 
mashed) 
7 ng/g * 156 g/portion = 1092 
ng/portions 
1092 ng/portion * portions/meal * 
frequency eaten/week = _ng 
intake/week 




52g per 125mL 










82g per 125mL 
(74g per ½ pepper 
raw) 
*Ffrq75 (Green 
peppers and green 
chilies) 
3.7 ng/g * 82 g/portion = 303.4 
ng/portions 
303.4 ng/portion * portions/meal * 
frequency eaten/week = _ng 
intake/week 




74g per 125mL 
(60g per ½ pepper 
raw) 
*Ffrq76 (Red 
peppers and red 
chilies) 
5.9 ug/kg * 1000 ng/ug * kg/1000g 
= 5.9 ng/g 
5.9 ng/g * 74 g/portion = 436.6 
ng/portions 
436.6 ng/portion * portions/meal * 














4.0 µg L-1 
s
  = 
4.0 ng/g 
250mL per cup 
*Bfrq4 (Tea (all 
types)) 
Avg. 3.5 ng/g 
3.5 ng/g * 250 g/portion = 875 
ng/portions 
875 ng/portion * portions/meal * 








1 ppm = 
1000ng/mL 





ww 66g per 125mL, 




3.8 ng/g * 66g/portion = 250.8 
ng/portion 
250.8 ng/portion * portions/meal * 
frequency eaten/week = _ng 
intake/week 
Information on the wet-weight (ww) nicotine content of vegetables and tea were sourced from 3 peer-
reviewed articles. Portion sizes were based on content per portion, as determined by Health Canada (Health 
Canada, 2008). Raw codes for ffrq and bfrq variables were converted into values that represent average 
weekly number of portions of that particular food item. 
• Xs = (Siegmund, Leitner, & Pfannhauser, 1999) 
• Xd = (Davis, Stiles, DeBethizy, & Reynolds, 1991) 
• XSH = (Sheen, 1988) 
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